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ABSTRACT

Centers for Disease Control and Prevention (CDC) estimate that more than 11.2 million
people require critical and emergency care in the United States per year [1]. Optimizing and
improving patient morbidity and mortality outcomes are the primary objectives of monitoring in
critical and emergency care. Patients in need of critical or emergency care in general are at a risk
of single or multiple organ failures occurring due to a traumatic injury, a surgical event, or an
underlying pathology that results in severe patient hemodynamic instability. Hence, continuous
monitoring of fundamental cardiovascular hemodynamic parameters, such as heart rate,
respiratory rate, blood pressure, blood oxygenation and core temperature, is essential to
accomplish diagnostics in critical and emergency care. Today’s standard of care measures these
critical parameters using multiple monitoring technologies.
Though it is possible to measure all the fundamental cardiovascular hemodynamic
parameters using the blood flow dynamics, its use is currently only limited to measuring
continuous blood pressure. No other comparable studies in the literature were successful in
quantifying other critical parameters from the blood flow dynamics for a few reasons. First, the
blood flow dynamics exhibit a complicated and sensitive dynamic pressure field. Existing blood
flow based data acquisition systems are unable to detect these sensitive variations in the pressure
field. Further, the pressure field is also influenced by the presence of background acoustic
interference, resulting in a noisy pressure profile. Thus in order to extract critical parameters from
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this dynamic pressure field with fidelity, there is need for an integrated framework that is
composed of a highly sensitive data acquisition system and advanced signal processing. In
addition, existing state-of-the-art technologies require expensive instrumentation and complex
infrastructure. The information sensed using these multiple monitoring technologies is integrated
and visualized using a clinical information system. This process of integration and visualization
creates the need for functional interoperability within the multiple monitoring technologies.
Limited functional interoperability not only results in diagnostic errors but also their complexity
makes it impossible to use such technologies to accomplish monitoring in low resource settings.
These multiple monitoring technologies are neither portable nor scalable, in addition to inducing
extreme patient discomfort. For these reasons, existing monitoring technologies do not efficiently
meet the monitoring and diagnostic requirements of critical and emergency care.
In order to address the challenges presented by existing blood flow based data acquisition
systems and other monitoring systems, a point of care monitoring device was developed to provide
multiple critical parameters by means of uniquely measuring a physiological process. To
demonstrate the usability of this novel catheter multiscope, a feasibility study was performed using
an animal model. The corresponding results are presented in this dissertation. The developed
measurement system first acquires the dynamics of blood flow through a minimally invasive
catheter. Then, a signal processing framework is developed to characterize the blood flow
dynamics and to provide critical parameters such as heart rate, respiratory rate, and blood pressure.
The framework used to extract the physiological data corresponding to the acoustic field of the
blood flow consisted of a noise cancellation technique and a wavelet based source separation. The
preliminary results of the acoustic field of the blood flow revealed the presence of acoustic heart
and respiratory pulses. A unique and novel framework was also developed to extract continuous

viii

blood pressure from the pressure field of the blood flow. Finally, the computed heart and
respiratory rates, systolic and diastolic pressures were benchmarked with actual values measured
using conventional devices to validate the measurements of the catheter multiscope.
In summary, the results of the feasibility study showed that the novel catheter multiscope
can provide critical parameters such as heart rate, respiratory rate and blood pressure with clinical
accuracy. In addition, this dissertation also highlights the diagnostic potential of the developed
catheter multiscope by presenting preliminary results of proof of concept studies performed for
application case studies such as sinus rhythm pattern recognition and fetal monitoring through
phonocardiography.
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CHAPTER 1: INTRODUCTION

1.1 Background
Optimizing and improving patient morbidity and mortality outcomes are the primary
objectives of monitoring in critical and emergency care. Patients in the need of critical or
emergency care in general are at a risk of single or multiple organ failure occurring due to a
traumatic injury, surgical event or an underlying pathology. This risk causes the patients to
experience a hemodynamic instability. This hemodynamic instability further leads to ineffective
circulating volume, cardiac function and/or vascular tone, ultimately resulting in an inadequate
tissue oxygen delivery, end organ perfusion and death. Today’s standard of care manages these
instabilities by continuously monitoring various cardiovascular hemodynamic parameters (critical
parameters) and thereby manipulating the macro and micro-circulation to improve tissue oxygen
delivery [2] [3] [4]. Minimum standards of monitoring in critical and emergency care are specified
by the college of intensive care medicine and they include continuous monitoring of fundamental
critical parameters such as heart rate, respiratory rate, blood pressure (arterial and venous), blood
oxygenation and core temperature [5]. From a systemic view, critical care monitoring can be
summarized as a two stage process. At the first stage, multiple sensors acquire vital bio-signals
corresponding to various physiological processes of the patient. At the second stage, a clinical
information system is used to integrate and visualize the data from the multiple sensors used in
first stage. State-of-the-art sensing technologies as shown in Figure 2.1, traditionally determine
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critical parameters from the vital bio-signals, i.e., heart rate is determined either from
Electrocardiogram (ECG) [6] or Photoplethysmograph (PPG) using 12 lead electrodes or a
fingertip pulse oximetry; respiratory rate is determined either from respiratory flow or
respiratory/lung sounds using a capnography or plethysmograph or a pneumatograph [7];
continuous blood pressure is determined by coupling the vascular pressures to an intravascular or
extravascular pressure sensor through an arterial and/or venous catheter [8] [9]; blood oxygenation
is determined from pulse oximetry [10] and core body temperature is measured using either a
pulmonary arterial catheter or a urinary Foley catheter [11].

Figure 1.1: Multiple Vital Bio-signal Monitoring in Critical and Emergency Care. Image
Adapted From [12].
1.2 Existing Challenges in Critical and Emergency Care Monitoring
Though it is possible to measure all the fundamental cardiovascular hemodynamic
parameters such as heart rate, respiratory rate, blood oxygenation and core temperature from the
blood flow, its use is currently only limited to measuring continuous blood pressure. No other
comparable studies in the literature were successful in quantifying multiple critical parameters
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from the blood flow dynamics for a few reasons. First, the blood flow dynamics exhibit a
complicated and sensitive dynamic pressure field. Second, existing blood flow based data
acquisition systems are unable to detect these sensitive variations within the dynamic pressure
field. Further, the dynamic pressure field is influenced by the presence of acoustic waves, resulting
in a noisy pressure profile. Thus in order to extract critical parameters from this dynamic pressure
field with fidelity, there is need for an integrated framework that is composed of a highly sensitive
data acquisition system and advanced signal processing. Even though monitoring heart rate and
cardiac arrhythmia is traditionally done using a 12-lead ECG, recent research shows that
morphological characteristics of ECG change due to electrolyte, water and other chemical changes
in the cardiovascular system. This change in chemical composition has a direct influence on the
electrical activity of the heart, resulting in false alarms and consequently, diagnostic errors. ECG
is known for producing the highest quality measurement of heart rate, but it has been shown in the
literature that heart rate measured from heart sounds is equally reliable as ECG [13]. Furthermore,
the 12 lead ECG and the respiratory data acquisition systems cause extreme discomfort and restrict
patient mobility. Although pulse oximetry is a gold standard monitoring technology for measuring
blood oxygenation, the characteristics of the PPG signal are not fully understood among the
medical community and it is still an area of active research [14] [15]. Also, blood oxygenation
measurements of PPG are inaccurate when partial pressure levels of oxygen are high, and the
inaccuracies also depend on properties of the skin which are highly subjective [16]. Further, core
body temperature sensing technologies require the use of an additional catheter rather than using
a preexisting arterial or venous line. Overall, the existing gold standard sensing technologies need
multiple assessment systems in order to monitor critical cardiovascular hemodynamic parameters
corresponding to various physiological processes. In addition, the existing clinical information
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systems face limitations to achieve medical device interoperability, as accomplishing the
integration and synchronization of various data acquisition systems used in the first stage is
complicated. Existing information systems also do not acquire and store high resolution data. As
a result, the complete morphology of the data acquired from various physiological sensors is not
currently being used for clinical interventions. In addition, the current systems do not support the
application of advanced data processing algorithms and consequently providing real time support
for clinical decision making still remains as an unsolved challenge [17]. All the limitations of
individual subsystems result in the following open challenges of critical and emergency care that
need to be addressed.
•

Expensive Instrumentation and Complex Infrastructure: To achieve minimum standards of
care, heart rate, respiratory rate, blood pressure, blood oxygen saturation and core body
temperature need to be continuously monitored as initial biomarkers of health status. This
implicates that the, use of 12-lead ECG, Capnography, Arterial Catheter, Plethysmography
and Foley Catheter is imperative. Not only these multiple monitoring technologies induce
extreme patient discomfort, but also demand complex infrastructure in terms of hardware
and software, in addition to being very expensive. For these reasons, current state-of-theart critical monitoring technologies are ineffective and so in order to address this challenge
of monitoring especially in low resource settings such as battlefields and emergency
scenarios, a new approach is required.

•

Medical Device Interoperability: In current critical and emergency care, vital bio-signals
are acquired from myriad physiological sensing technologies. Due to most of these
technologies being stand-alone devices, they do not integrate with each other creating a
limited functional interoperability. This lack of functional interoperability leads to issues
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associated to time synchronization of the data acquired from various physiological
processes, eventually leading to diagnostic errors. In addition, due to the limited
interoperability, critical care diagnostics is subject to high false alarm rate. Though many
solutions have been proposed to address this issue, interoperability remains as an open
challenge to date.
•

Portability and Scalability: It has to be underlined that, existing critical and emergency
care monitoring and diagnostic technologies are neither portable nor scalable. As a result,
additional monitoring and diagnostic technologies are continuously brought in to meet the
requirements of standard of care. The novel system presented in this work is portable,
scalable and possibly applicable to multiple case studies of critical and emergency care.

1.3 Motivation and Research Objectives
Accomplishing monitoring from the dynamics of the blood flow is currently limited to
measurement of continuous blood pressure. The hypothesis of this research is that, it is possible to
extract other critical parameters such as heart rate, respiratory rate, blood oxygenation, and core
temperature from the blood flow dynamics. Thus, our primary motivation of this research is to
develop a novel point of care monitoring device that is capable of providing multiple critical

Figure 1.2: Critical and Emergency Care Monitoring Using Novel Catheter Multiscope.
5

parameters by uniquely characterizing a physiological process, i.e., blood flow dynamics. Figure
1.2 shows a basic overview of the concept of operations for the catheter multiscope monitoring
critical parameters from a subject in critical and/or emergency care.
Figure 1.3 shows the life cycle representation of the medical device development.
Following the lifecycle, proof of concept and feasibility studies will be carried out to evaluate the
usability of the catheter multiscope for critical care using a small animal model [18]. The proposed
novel catheter multiscope is an enhanced version of the electronic catheter stethoscope [19] with
respect to its data acquisition. In particular, the limitations of the existing blood flow based data
acquisition systems in detecting the sensitive variations within the dynamic pressure will be
addressed through integration of the enhanced data acquisition system and an advanced signal
processing framework. The proposed novel catheter multiscope is expected to be a disruption in
technology, such that, it will be potentially possible to address open challenges such as the need
for expensive instrumentation and complex infrastructure; improvement in the diagnostic precision
in low resource settings; and functional interoperability. Further, the developed signal framework
will also be extended to highlight the diagnostic potential of this technology for various case study
applications. Specifically, proof of concept studies will be performed on applications such as sinus
rhythm pattern recognition and fetal monitoring through phonocardiography. The proof of concept
studies will demonstrate that the catheter multiscope can also be configured to be scalable and
portable.

Figure 1.3: Medical Device Life Cycle.
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1.4 Contributions
A novel critical and emergency care monitoring system has been developed to measure
heart rate, respiratory rate, systolic and diastolic pressure with clinical accuracy from the blood
flow dynamics.
•

Designed an innovative data acquisition system to uniquely characterize the blood flow
dynamics.


The data acquisition system was designed to precisely characterize the sensitive
dynamic pressure variations of the blood flow using a fluid coupled catheter and a novel
polymeric membrane to act as fluid to air coupler.



The data acquisition system was also designed to deliver the pressure field without any
distortions while minimizing other interferences using a waveguide.

•

Developed an innovative signal processing framework to extract vital bio-signals and the
corresponding signal processing algorithms to compute critical parameters from the
acquired blood flow dynamics.


Developed an efficient noise reduction algorithm to improve the signal to noise ratio
of the acquired dynamic pressure field.



Developed a source separation algorithm to separate the data corresponding to various
acoustic sources from a single channel observation.



Developed a validation metric to estimate the performance of denoising when the
channel noise is not available.

•

Developed a procedure to validate and benchmark the performance of the proposed critical
and emergency care data acquisition system.
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Accomplished validation by comparing the critical parameters derived from the novel
catheter multiscope to critical parameters derived from conventional measurement
systems.

In addition to demonstrating the feasibility of the developed novel catheter multiscope in
critical and emergency care monitoring, the diagnostic potential of the developed technology has
been shown in the following case studies.
•

Accurately recognized the sinus rhythm patterns using acoustic heart pulses from the novel
catheter multiscope.

•



Developed a new feature called multiscale energy.



Developed a pattern recognition framework based on K-Means clustering.

Extracted the vital bio-signals of fetal phonocardiograms with fidelity.


Implemented the catheter stethoscope’s noise reduction and source separation
framework to separate fetal and maternal heart sounds corresponding to various signal
to noise ratio conditions of simulated fetal phonocardiograms



Validated the denoising and separation fidelity using validation metrics of the
developed catheter multiscope.

In comparison to the existing state-of-the-art, the developed critical and emergency care
monitoring technology exhibits innovation in terms of complexity of the data acquisition system
and a signal processing framework. The proof of concept and the feasibility studies show that the
developed minimally invasive catheter multiscope can be used to measure critical parameters with
clinical accuracy. It is expected that this dissertation will serve the needs of scientists, researchers,
clinicians and other readers involved in the research and development of medical devices and
biomedical signal processing.
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1.5 Dissertation Organization
The research that has been performed is organized and presented in the following chapters.
1.5.1 Chapter 2: Survey of Critical and Emergency Care Monitoring Systems
In this chapter, the background information about critical and emergency care monitoring
and diagnostics is described. The diagnostic relevance of monitoring specific hemodynamic
cardiovascular vital bio-signals in the critical and emergency care are also highlighted. A literature
review on existing state-of-the-art critical care sensing technologies and clinical information
systems is included in this chapter. In addition, a comprehensive introduction to various
physiological signals (vital bio-signals) is presented from the perspective of the signal processing
field.
1.5.2 Chapter 3: Data Collection
In this chapter, an overview of the human circulation system from the perspective of fluid
mechanics and how various physiological systems influence the blood flow dynamics is provided.
Then, how the data was collected for the feasibility study is described. Based on the fluid
mechanics understanding of the human circulatory system, the interpretation of the collected data
is provided. Finally, the chapter is concluded by laying the foundation for the development of the
signal processing framework.
1.5.3 Chapter 4: Signal Processing Framework
In this chapter, a functional overview of the signal processing framework that was
implemented to compute the vital bio-signals and critical parameters is provided. Further, a
comprehensive description of the developed noise cancellation, the wavelet source separation and
the novel blood pressure computation framework is presented. In addition, performance
comparison results of various noise cancellation algorithms are provided. Finally, the chapter is
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concluded by describing the validation results of wavelet source separation and blood pressure
computation.
1.5.4 Chapter 5: Application Case Studies
In this chapter, an overview of special applications such as sinus rhythm pattern recognition
and fetal monitoring through phonocardiography is provided. Further, a detailed description and
results of feature extraction and pattern recognition framework for sinus rhythm pattern
recognition are provided. Then, the chapter is concluded by providing the results of the noise
cancellation and source separation techniques on the simulated fetal phonocardiograms.
1.5.5 Chapter 6: Conclusions and Future Research
A summary of the findings of this research is provided in this chapter. Then, directions for
future research with respect to the data acquisition system design, data collection and signal
processing framework have been provided in this chapter. In particular, the specifications and
design for future generations of the data acquisition system is described. In addition, future
directions for additional application case studies are also provided.
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CHAPTER 2: REVIEW OF CRITICAL AND EMERGENCY CARE MONITORING
PARAMETERS AND SYSTEMS

2.1 State-of-the-Art in Critical and Emergency Care Monitoring
Critical and/or emergency care begins with minimum standards of monitoring. However,
depending on the status of the patient, a full spectrum of hemodynamic cardiovascular parameters
come into play that aid in determining the future clinical interventions. The complete set of critical
parameters can be classified into four groups. They are pressure, cardiovascular, respiratory and
miscellaneous. In addition to the parameters, their respective sensing technologies are also shown
in Table 2.1. In addition to the traditional sensing technologies, a number of other alternative
technologies are often employed to estimate other critical hemodynamic and respiratory
parameters. This chapter provides an introduction to the morphology of all the vital bio-signals,
an overview of all the fundamental hemodynamic parameters, a review of the existing sensing
technologies, clinical information systems and other frequently used alternative technologies.
Table 2.1: Critical and Emergency Care Cardiovascular Hemodynamic Parameters.
Cardiovascular Parameters
Sensing Technology
ECG, PCG, Pulseoximetry, Blood
Heart Rate (HR)
Pressure
Dilution Methods, Pulse Wave Velocity
Cardiac Output (CO)
Analysis and Bioimpedance
Pressure Parameters
Mean Arterial Pressure (MAP)
Central Venous Pressure (CVP)
Mean Pulmonary Arterial Pressure (MPAP)
Pulmonary Arterial Occlusion Pressure (PAOP)
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Sensing Technology
Arterial Catheter
Central Venous Catheter
Pulmonary Arterial Catheter
Pulmonary Arterial Catheter

Table 2.1 (Contd.)
Respiratory Parameters
Respiratory Rate (RR)
End Tidal Carbon-dioxide Pressure (ETCO2)

Sensing Technology
Capnogram, Pneumatograph and ECG.
Capnogram

Miscellaneous Parameters
Peripheral Oxygen Saturation (SPO2)

Sensing Technology
Pulseoximetry
Blood Sampling Analysis and
Pulseoximetry
Blood Sampling Analysis
Blood Sampling Analysis
Blood Sampling Analysis
Blood Sampling Analysis
Blood Sampling Analysis
Pulmonary Arterial Catheter and Foley
Catheter

Arterial Hemoglobin Saturation (SAO2)
Arterial Oxygen Tension (PAO2)
Mixed Venous Oxygen Saturation (SVO2)
Mixed Venous Oxygen Tension (PVO2)
Arterial pH (pH)
Hemoglobin (Hgb)
Core Temperature (T)

2.1.1 Electrocardiogram (ECG)
ECG is a graphical representation of the electrical activity of the cardiovascular system.
The wave-like pumping action of the heart is controlled by a network of neural fibers that are
distributed throughout the myocardium and coordinate its regular contraction and relaxation. The
myocardial stimulation starts from the Sinoatrial Node (SA-node). The SA-node is a cluster of
cells located in the upper-right posterior wall of the right atrium, which sends the electrical impulse
that triggers each heartbeat. This impulse further stimulates the second cluster of cells, namely the
Atrioventricular Node (AV-node) that is situated in the lower posterior wall of the right atrium.
After the AV-node, the depolarization front enters the bundle of His, the left and right bundles,
and ends in the Purkinje fibers, depolarizing the ventricular muscles in its way. The procedure of
myocardium contraction is known as the depolarization (or systole) cycle that is followed by the
repolarization (or diastole) cycle, in which the myocardium relaxes and becomes ready for the next
activation. A complete cardiac cycle is depicted in Figure 2.1. This cardiovascular electrical
activity is transmitted throughout the body and can be measured across the chest using either 1-
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lead or 3-lead or 5-lead or 6-lead or 12-lead skin electrodes. For critical and emergency care, 12lead ECG is considered the gold standard, due to its measurement accuracy [20].
The ECG measured on the body surface is a result of the stage-wise activation of the
myocardium and results in the PQRST-complex depicted in Figure 2.1. The P-wave is the result
of the atrial depolarization. This depolarization starts at the SA-node and spreads to ventricles
through the AV-node. The QRS complex represents the ventricular depolarization. Then, atria and
ventricles repolarize. However, atrial repolarization is obscured by the QRS complex and ventricle
repolarization is represented through the T wave [21]. One of the main uses of ECG in the critical
and emergency care is continuous monitoring of heart rate. The heart rate represents the time
consumed by the heart to complete one cardiac cycle. The HR is one of the high priority critical
parameters and is typically measured as the time interval between current and previous R-waves
of ECG. Arrhythmias are other leading cause of death among critical and emergency care patients.
Hence, many critical and emergency care units detect arrhythmia through continuous ECG
monitoring. In addition, ECG is also used to provide complimentary information about respiratory
system through RR computation [22]. Though ECG provides significant diagnostic information,
its use is limited due to some critical challenges. ECG data acquisition is complex and due to this,
it is known to induce discomfort and restrict patient mobility. Studies like [23] [24] have often
shown that morphological characteristics of the ECG change due to electrolyte, water and other
chemical changes in the cardiovascular system. In the context of critical and emergency care,
drugs, medication and nutrients are frequently delivered to induce changes in the micro and macro
circulation. This often leads to changes in the cardiovascular system’s electrolyte composition.
This composition change will result in diagnostic errors and false alarms due to the changes in the
ECG’s morphological characteristics. Hence, there is an increased need to develop a medical
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device that provides reliable and consistent results even during chemical composition change in
the cardiovascular system and that addresses other ECG limitations. In addition to the ECG, an
alternative technology that records acoustic activity of the heart is often used. This is known as
phonocardiogram and it provides vital information with respect to cardiovascular abnormalities
[13].
2.1.2 Blood Pressure (BP)
High blood pressure is a leading risk factor responsible for high cardiovascular morbidity
and mortality rates. Hence, precise and accurate monitoring of continuous blood pressure is
imperative in critical and emergency care. The main function of the human circulatory system is
to transport oxygen and other nutrients to the tissues and to carry waste away from the cells. The
nutrients and the oxygen are carried to various parts of the body through oxygenated blood flow
via arteries, and waste through deoxygenated blood flow via veins. The blood flows in the blood
vessels due to the pumping action of the heart. The heart can be divided into four chambers and
two pumping systems. Each pump has a filling chamber known as the atrium, which helps to fill
a pumping chamber known as the ventricle. The oxygenated blood flows from the lungs into the
left ventricle through left atrium and mitral valve. The left ventricle then ejects the blood into the
aorta through the aortic value. Blood is then distributed to various parts of the body through
branching network of arteries, arterioles and ventricles. Similar to the arterial system, the
deoxygenated blood from different parts of the body reaches the right atrium through the venous
system. The deoxygenated blood flows into the right ventricles through the tricuspid valve and
into the pulmonary artery through the pulmonary valve. During diastole, the atria contract to
generate sufficient pressure to open the mitral and tricuspid valves, thereby filling the ventricles.
Then, during systole, aortic and pulmonary valves open due to pressure generated by ventricular
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contraction. This mechanical contraction of the ventricles forces the blood to flow in arteries and
veins [8]. In effect, the flowing blood exerts pressure onto the walls of the blood vessels
contributing to blood pressure.

Figure 2.1: Morphology of the Electrocardiogram. Data Obtained from MIT–BIH Long-Term
ECG Database [25].
Many technologies exist to measure blood pressure. They can be classified into three
groups based on the measurement technique: invasive, oscillometric and unobtrusive, also known
as cuffless. In the context of critical and emergency care, since continuous monitoring of the blood
pressure is imperative, invasive blood pressure measurement is considered to be the gold standard.
Invasive blood pressure measurement typically involves the use of a catheter. Based on the location
of the sensing element, invasive measurement can be further classified into intravascular and
extravascular measurement systems. In the extravascular pressure measurement systems, the
vascular pressure is fluid coupled to an external sensing element. The catheter is inserted into the
arterial or venous system through a cannula, where the proximal end of the cannula is immersed
in the blood and the distal end is connected to the proximal end of the fluid filled catheter. The
distal end of the fluid filled tube is connected to either a drug delivery system or a saline delivery
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system. The column that couples the vascular pressure through fluid to the diaphragm of the
pressure transducer is housed before the drug delivery system as shown in Figure 2.2.

Figure 2.2: Invasive Extravascular Pressure Measurement System.
On the other hand, in the intravascular pressure measurement systems, the sensing element
is housed at the tip of the catheter and is placed directly into the vascular system. Among noninvasive blood pressure measurement techniques, the oscillometric technique is a widely used
method. The oscillometric techniques estimate the blood pressure through auditory detection of
the turbulent blood flow sounds occurring due to inflation of the occlusive cuff around an artery.
These turbulent blood flow sounds are detected using a stethoscope by stepwise deflation of the
inflated cuff. The pressure detected at the first and the last instances of the turbulent blood flow
sounds are considered to represent pressure during systole and diastole, respectively. Unobtrusive
blood pressure monitoring methods are among recent developments and are still under research.
The objective of unobtrusive monitoring is to estimate blood pressure continuously and noninvasively. Existing unobtrusive methods estimate blood pressure by linearly or nonlinearly
modeling the pulse transit time or the pulse wave velocity. Pulse transit time or pulse wave velocity
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is currently being measured using either electrical, optical, magnetic, mechanical or impedance
based sensing technologies [8] [26] [27].
It is worth noting that the blood pressure is different at various body sites. In particular,
arterial pressure, central venous pressure and pulmonary arterial pressure are the most widely
monitored vital bio-signals in critical and emergency care. Arterial pressure is representative of
pressure of blood exerted on the walls of arteries. This pressure is commonly measured in radial,
femoral, carotid arteries or aorta through the use of an arterial catheter. The arterial pulse is a
forward propagating pressure wave that is generated due to stroke volume changes during each
cardiac cycle. The arterial pressure waveform is a periodic waveform that can be represented as a
summation of six sinusoidal components. Each local maxima in the waveform occurs when the
ventricle contracts and forces the blood into the aorta, this is referred to as systolic pressure.
Similarly, local minima in the waveform occur after the aortic valve closes and when the ventricles
relax; this is referred to as diastolic pressure. In addition, the arterial pressure waveform also
reflects the valve closure as a high frequency interruption in the signal and it is commonly referred
to as the dicrotic notch. As the pressure reaches the minima, the aortic valve opens and the blood
starts flowing into the aorta, usually seen as an increasing signal with positive slope and the
pressure reaches a local maxima. This process periodically repeats for each cardiac cycle [28].
From the arterial blood pressure vital bio-signal, critical parameters such as systolic, diastolic and
mean arterial pressures are estimated. The critical parameters estimated from arterial blood
pressure vital bio-signal contain information with respect to afterload, i.e., tension developed by
the myocardium during ventricular systolic ejection [5] [29]. In addition to the after load,
information with respect to preload is also another parameter that is measured in critical and
emergency care. Preload provides information with respect to intravascular volume, i.e., amount
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of blood returned to the heart which is reflective of perfusion abnormalities. This is accomplished
by measuring CVP, i.e. pressure in the right atrium, using a central venous catheter. The CVP
waveform is typically represented by acxvy components. Each component of the CVP waveform
has a direct relevance to the events of a cardiac cycle [30]. Pulmonary arterial pressure is another
vital bio-signal that is continuously monitored for high risk patients in critical and emergency care.
The pulmonary arterial pressure is measured using a balloon tipped Swan-Ganz catheter. The
Swan-Ganz catheter is typically placed in pulmonary artery and the pressure is recorded. In
addition, when the balloon tip of the catheter is inflated and placed in a branch of the pulmonary
artery, the measurement results in the PAOP. The waveforms of the pulmonary arterial pressure
and the PAOP are also characterized by the a, the c and the v components. MPAP and mean PAOP
(MPAOP) are the critical parameters that are computed from pulmonary arterial pressure signals
[31] [32]. In addition to pulmonary arterial catheter, recent developments have led to the
assessment of MPAP and MPAOP using ultrasound technology [33] [34] [35]. Figure 2.3 shows
various waveforms collected as of part of intensive care monitoring in The Massachusetts General
Hospital and published as “The MGH/MF Waveform Database” in the PhysioNet databank [36]
[25].
Various technologies exist to assess the pressure based vital bio-signals and the
corresponding critical parameters. In the context of critical care, catheter based pressure
measurements are considered to be gold standard to date. However, these catheter based pressure
measurement systems provide limited information. As of today, these systems only provide blood
pressure information. However, in order to get information with respect to other fundamental
critical parameters, today’s standard of care has to rely on other technologies. With few
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modifications, the catheter based systems will be able to provide all the fundamental critical
parameters. This is one of the main challenge that is addressed in this dissertation.

Figure 2.3: Morphology of ECG, ART, PAP, CVP Bio-signals. Data Obtained from [36] [25].

2.1.3 Cardiac Output (CO)
Cardiac output is one of the most important critical parameters that is continuously
monitored for high risk patients in critical and emergency care. It is defined as the volume of blood
pumped by the heart per minute. CO is a widely used diagnostic tool to detect various conditions
including cardiovascular shocks and also to determine if fluid resuscitation and other medications
are needed based on the hemodynamic profile. Traditionally in critical and emergency care, CO is
measured using a pulmonary arterial catheter and a dilution technique. In the dilution techniques,
an agent of known concentration and temperature is injected into the right atrium through the distal

19

end of the pulmonary arterial catheter. Due to constant stroke volume change, the concentration of
the mixture of agent and blood starts reducing and the temperature of the blood changes. This
change in the temperature of the blood is monitored constantly as the thermodilution curve. The
measured temperature and the initial volume of the agent in combination will be used to determine
the CO [37]. CO can also be estimated using ultrasound and echocardiography, in particular, the
distance traveled by a column of blood for each cardiac cycle is estimated, i.e., blood flow velocity.
The measured blood flow velocity is directly proportional to stroke volume and hence CO. CO can
also be estimated using technologies that involve bioimpedance and pulse contour analysis
techniques. In the bioimpedance method, the change in the impedance of the electrodes placed on
the chest is directly correlated to the blood volume change used to estimate the CO. On the other
hand, the pressure pulse velocity is determined using either electrical, optical, magnetic,
mechanical or impedance based sensing technologies which can be linearly or nonlinearly modeled
to estimate CO. Based on the techniques discussed, various alternative sensing technologies have
been developed to provide information with respect to CO as described in [38] [39].
2.1.4 Capnography
Continuous monitoring of the cardiorespiratory system is essential to provide necessary
ventilation support for patients in critical and emergency care. Although, different parameters
provide relevant information with respect to the respiratory system, RR and ETCO2 are the
essential critical parameters being used today. They are typically derived from the capnogram, a
vital bio-signal. Capnography is a method used to detect the concentration of carbon-dioxide in a
sample of gas. The sample of gas exchanged by the patient is collected either through a nasal
cannula or through an intubation tube for absorption spectroscopic analysis. As the carbon-dioxide
absorbs the infrared light, the transmitted spectra is analyzed and calibrated to provide the
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concentration of carbon-dioxide in the subject’s gas sample. Measuring and tracing this carbondioxide concentration over time will result in the vital bio-signal called capnogram. The
capnogram is a periodic waveform that represents events of a complete respiratory cycle. The
events of respiratory cycle are inspiration, expiratory stroke, expiratory plateau and expiratory
downstroke. During inspiration, the concentration of the carbon dioxide remains to be at a
consistent baseline line, then as the expiratory begins, the alveolar gases get emitted. The alveolar
gases predominantly contain carbon dioxide and hence its concentration begins to reach a local
maxima, i.e., gets plateaued. After the complete volume of alveolar gases get expired, the
inspiration begins. Right after inspiration, and before expiratory plateau, there is a momentary
dead space when the both the inspiratory and alveolar gas exchange ends, this region is known as
expiratory stroke. Also, as soon as the concentration of carbon dioxide reaches a local maxima,
there exists some dead space when both the expired and inspired gas exchange end, this is known
as the expiratory downstroke. From this waveform, critical parameters, RR and ETCO2 are
computed. RR is computed as time expired for both inspiration and expiration per minute; ETCO2
is the maximum concentration of the CO2 in the expired gas i.e., the local maxima of the event
expiratory plateau. In addition to time-based capnogram, volume based capnogram is also widely
used. Additional details on capnography based cardiorespiratory monitoring and trends in
capnography technologies are presented in [40] [41] [42]. In addition, volume based critical
parameters such as tidal volume, vital and total lung capacities are measured using spirometers,
pneumatographs and other alternative technologies [43].
2.1.5 Plethysmograph
Ensuring oxygen delivery to tissues is one of the main objectives of the cardiorespiratory
system. During respiration, the inspired oxygen in the lungs bind to deoxygenated blood, making
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it oxygenated blood. Most of the oxygen in the lungs bind to hemoglobin. Small amount of oxygen
dissolves in the blood plasma. This oxygenated blood is then pumped out of the heart into the
aorta, and then into the arteries, arterioles and eventually into the capillary networks. These
networks of capillaries supply tissues with oxygen and nutrients. Plethysmograph is a tracing of
the amount of oxygen that is bound to hemoglobin at the tissue level, also known as SPO2. The
oxygenated and deoxygenated hemoglobin levels in the blood are detected using absorption based
infrared spectroscopy transcutaneously. The vital bio-signal waveform obtained using
spectroscopy is known as plethysmography or pulse oximetry. This waveform contains
information with respect to arterial blood, tissue, and respiration. It contains an AC and a DC
component. The percentage of SPO2 is the critical parameter that is calculated using amplitude
ratios of both the AC and the DC components of plethysmography. It has to be noted that, SPO2
is considered to be an indirect measurement of SAO2. Additional details of the plethysmography
are described in [44] [45].
2.1.6 Miscellaneous Critical Parameters
Arterial hemoglobin saturation (SAO2), arterial oxygen tension (PAO2), mixed venous
oxygen saturation (SVO2), mixed venous oxygen tension (PVO2), arterial pH (pH), hemoglobin
(Hgb) and core temperature (T) are among the other miscellaneous critical parameters that are
often measured in critical and emergency care. SAO2 is the measurement of concentration of
oxygenized hemoglobin in the arterial blood and PAO2 is the measurement of concentration of the
oxygen dissolved in arterial blood plasma. In addition to critical parameters corresponding to the
arterial blood, parameters corresponding to venous oxygenation such as SVO2 and PVO2 are also
measured. SVO2 is the measurement of oxygen concentration bound to hemoglobin in venous
blood, and PVO2 is the measurement of oxygen concentration dissolved in venous blood plasma.
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These parameters are measured using either blood sampling analysis or by using an indwelling
fiber optic catheter. In blood sampling analysis, a column of blood is sampled from either an
arterial or a venous body site and is subjected to spectroscopic analysis using blood gas analyzers.
In order to measure the concentration of the blood plasma in arterial or venous blood, the blood
cells are separated from blood plasma either using centrifugal techniques or using a reagent. Then,
the plasma is made to interact with a metal testing strip to determine the concentration of
compounds of interest in the plasma. In addition, various alternative techniques involving
spectroscopy systems in combination with linear and nonlinear modeling are being developed for
rapid blood analysis. It also has to be noted that, other parameters such as total hemoglobin,
concentration of other electrolytes and acidity level within the blood are monitored for patients
with advanced risk in critical and emergency care. Core temperature is also a parameter that is
usually measured from a sample extracted from either pulmonary arterial catheter or urinary Foley
catheter. Additional information regarding miscellaneous parameters and electrolyte concentration
is provided in [46] [47] [48] [49].
2.1.7 Clinical Information Systems
It is well established that there are several vital bio-signals corresponding to various
physiological processes that must be continuously monitored in critical and emergency care. In
addition, various critical parameters corresponding to the vital bio-signals are also continuously
computed and monitored. A clinical information system is often employed in critical and
emergency care to integrate and visualize the critical parameters and vital bio-signal collected from
corresponding physiological processes. As of today, several clinical information systems are
commercially available to provide end-to-end solutions to integrate diverse patient sensing or
monitoring systems. It is estimated that the market value for these system has exceeded $1.3 billion
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due to the volume of information available in the intensive and emergency care setting. Currently,
GE’s Centricity and Philips IntelliVue Clinical Information Portfolio are the most commonly used
commercial critical and emergency care information systems [17]. The vital bio-signals
corresponding to various physiological processes are typically generated by standalone sensing
technologies and either analog or digital data is available depending on the technology. The data
available from these technologies is integrated through either a serial (RS-232 or I2C or USB),
Ethernet (802.3) port or using wireless (802.11b/g or Bluetooth) communication for digital data.
For analog data, standard hardware interfaces are used. Though, high resolution physiological data
is not collected, snapshots of the acquired vital bio-signals and critical parameters are displayed
on monitors to aid in the clinical decision making. In addition, a standard architecture to integrate
and acquire continuous physiological data is yet to be established. Recent developments in clinical
information systems can be found in [17].
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CHAPTER 3: DATA COLLECTION

3.1 Fluid Mechanical Perspective of Blood Circulation
The circulatory system can be described as a closed loop system that is directly regulated
by the cardiovascular system and the respiratory system and controlled by the nervous system. As
a result, the dynamics of the blood flow is influenced by factors such as length of cardiac cycle,
stroke volume, rate of respiration, volume of respiration and baroreflex control. This complex
interrelationship within various subsystems of the human body make the dynamics of the blood
flow an interesting phenomenon. Several studies in the literature have underlined the significance
of various factors that affect the blood flow, Cardiac Output (CO), i.e., the amount of blood
pumped by the heart per minute, which is usually computed as a product of HR and stroke volume.
Thus, increasing the heart rate or increasing the contractile strength of the ventricles, i.e., stroke
volume, CO can be increased. In addition, it is well established that variability of heart rate is
influenced by the baroreflex control and the breathing in the form of Meyer waves and respiratory
sinus arrhythmia [50] [51]. In addition to CO, blood flow dynamics is also affected due to the
properties of the arteries and veins. The properties of the arteries and veins such as elasticity,
vascular resistance and thus the diameter of the corresponding blood vessels are controlled by the
baroreflex feedback [52] [53]. Studies have also shown that baroreflex controls the dynamics of
the blood flow based on the respiratory parameters such as volume and rate of respiration [54] [55]
[56] [57] [58].
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The circulatory system can be approximated as a fluid pumping system as shown in Figure
3.1. In Figure 3.1, the deoxygenated blood is collected from the organs and is sent to the lungs.
Then, the oxygenated blood is collected from the lungs and is distributed to the organs. According
to Bernoulli’s principle, the total energy of any frictionless fluid flow is conserved. As a result,
blood flow in the blood vessels can be described using Bernoulli’s principle. The total energy of
the blood flow in any blood vessel is the summation of its static pressure, dynamic pressure and
gravitational head. The static pressure of the fluid is the pressure generated due to the force exerted
by all the fluid elements on each other i.e. intramolecular pressure. In the case of steady state flow,
the static pressure is directly dependent on the volumetric flow rate of the fluid. Due to this static
pressure, the blood exerts pressure in all directions including on the walls of the blood vessels,
contributing to blood pressure. In addition, since the blood is pumped with some velocity by the
ventricular contraction during each cardiac cycle, the fluid also contains kinetic energy that is
directly proportional to its velocity. This kinetic energy is often referred to as dynamic pressure.
In addition, the pulsatile flow of blood influences the flow within the blood vessels with an
unsteady acceleration. Overall, the pressure wave propagates mainly due to radial and axial fluid
motion. While radial motion is due to the static pressure, axial motion is due to the dynamic
pressure [8] [59]. Also, since the pressures are acquired at an increased elevation, the fluid also
exhibits gravitational head due to the weight of the fluid. As of to date, blood flow has been mainly
used to obtain information with respect to blood pressure. However, since the blood flow dynamics
contain a plethora of information in the form of multi-dimensional pressure wave with regards to
various cardiovascular, respiratory, and other subsystems, the blood flow dynamics was selected
as a phenomenon of interest to obtain multiple critical parameters. In this dissertation, a novel data
acquisition system was designed to characterize the blood flow dynamics and to obtain information
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with respect to multi-dimensional pressure field. The details of the design and the data collection
are provided in the following sections 1,2.

Figure 3.1: Fluid Pumping System Approximation of Circulatory System.
3.2 Data Acquisition System Design
Figure 3.2 illustrates the block diagram overview of the data acquisition system that was
used to determine multiple vital bio-signals from the animal model. As shown in Figure 3.2, the
system includes a silicone or polyvinylchloride catheter comprising a flexible tube that is
configured for insertion in a subject’s blood vessel, such as an artery or vein. When inserted, the
distal end of the catheter is immersed in the blood that flows through the vessel. The proximal end
of the catheter is received by, and therefore connected to, a coupling member that is, in turn,
connected to a waveguide. As is also shown in Figure 3.2, a port has been provided along the

1

The content described in Chapters 3 and 4 are part of US provisional [122] and utility patent applications [123].
A preliminary version of the content presented in Chapter 3 and 4 have been published in the proceedings of 39th
annual international conference of the IEEE Engineering in Medicine and Biology Society [121].
2
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length of the catheter between its distal and proximal ends that can be used to flush the catheter
with an appropriate fluid, such as saline solution. Mounted to the coupling member is a flexible
barrier. This barrier is formed using a thin polymeric membrane that is on a first side in fluid
communication with the blood delivered to the coupling member by the catheter and on a second
side in fluid communication with air contained within an interior air chamber of the waveguide.
At the proximal end of the waveguide, a pressure field microphone isolated from the environment
is housed to measure the pressure within the waveguide. The waveguide that is housing the
pressure field microphone is mounted on a vibration isolating stainless steel tray. In addition, a
free field microphone placed within close proximity to the subject is also used to measure reference
acoustic noise. Specifically, the free field microphone is directed towards the subject using a
stainless steel holder mounted on a tripod. It also has to be noted that both pressure and free field
microphones were located at the same elevation from the ground as that of the subject and forming
an angle less than 45o among themselves during the measurement. In the current feasibility study,
a GRAS 46 AD, a pressure field microphone with frequency response of 3.15 Hz – 10 kHz and a
G.R.A.S 46 AE, a free field microphone, have been used to measure pressure field and reference
acoustic noise respectively [60] [61]. Since both G.R.A.S microphones require a constant current
power supply of 4 mA and 24 V for optimal performance, a National Instruments PXI 4462 system
is used to provide constant power to the microphones through a British naval connector. The
measured data from both the channels was digitized and stored at a sampling frequency of 10 kHz
and 24 bit quantization rate using PXI 4462 system and LabVIEW data acquisition drivers [62].
As shown in Figure 3.2, the waveguide is designed to be conical and special attention has been
paid to estimate the ideal distance between the barrier and the microphone based on the length of
the sensing element. These design considerations have enabled maximal energy transfer while
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attenuating the effects of reflections and reverberation and without distorting the frequency of the
actual pressure wave.

Figure 3.2: Block Diagram Representation of the Data Acquisition System.
3.3 Data Collection Approach
The data collection approach defines type and location of the data being acquired. Vascular
pressures were obtained from various arterial and venous body sites of an anesthetized Yorkshire
pig in supine position. The obtained vascular pressures were coupled from the subject to the
extravascular pressure field microphone through a fluid coupled catheter using a preexisting
arterial or venous line. A total of twelve pressure measurements were obtained from six different
body sites as part of this study. Two different pressure measurements were obtained at each body
site, one without the influence of epinephrine and other with influence of epinephrine. Table 3.1
illustrates the sequence in which the design of experiments was conducted for all the acquired
pressure measurements. In addition, heart rate, respiratory rate and blood pressure were measured
prior to and post the vascular pressure acquisition for the purpose of benchmarking. These
parameters were obtained from the state-of-the-art Philips IntelliVue critical care clinical
information system. It has to be noted that, this study was performed by strictly adhering to ethical
standards of the Institutional Animal Care & Use Committee. In addition, all the animal studies
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corresponding to this research were performed at the University of South Florida’s Center for
Advanced Medical Learning and Simulation facilities eCath laboratory. Appendix B contains
relevant documentation with regards to IACUC approval for the animal studies.
Table 3.1: Design of Experiments For Measured Blood Flow Dynamics.
Recording
Catheter
Body Site
Epinephrine
Index
Size
1a
Artery
Carotid
Left Side of Neck
5F
No
1b
Artery
Carotid
Left Side of Neck
5F
Yes
2a
Venous
Jugular
Right Side of Neck
5F
Yes
2b
Venous
Jugular
Right Side of Neck
5F
No
3a
Venous
Femoral
Right Leg
4F
No
3b
Venous
Femoral
Right Leg
4F
Yes
4a
Venous
Femoral
Left Leg
6F
Yes
4b
Venous
Femoral
Left Leg
6F
No
5a
Artery
Peripheral
Left Ear
20F
No
5b
Artery
Peripheral
Left Ear
20F
Yes
6a
Artery
Femoral
Left Leg
5F
No
6b
Artery
Femoral
Left Leg
5F
Yes
3.4 Description of the Measurements
The blood flows from the venous or arterial body site into the catheter and reaches the
flexible barrier that stagnates the flow of blood and ultimately acts as a fluid to air coupler. At this
boundary, the blood column oscillates and this oscillation depends on the frequency of stagnation
pressure of the blood flow, i.e., the frequency at which the blood is being pumped. The stagnation
pressure that is impinged onto the barrier induces a pressure field in the waveguide. According to
the basic principles of fluid mechanics, the total pressure (Ptotal) is the sum of static pressure (Pstatic)
and dynamic pressure (Pdynamic) [63]. Pstatic results from intramolecular interaction and Pdynamic
results from the velocity of the blood flow. These pressures are traditionally measured using a
combination of piezometer and Pitot tube. Based on the configuration in which the pressure field
microphone was arranged to acquire pressure data, it was considered that the measured pressure is
Ptotal. In order to understand how the stagnation pressure or total pressure is being measured,
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Bernoulli’s equations are used in the following derivation as means to provide a theoretical
understanding of the measurements. Figure 3.3 presents a zoomed in view of the data acquisition
system that was used is measuring Ptotal of the blood flow.

Figure 3.3: Zoomed in View of the Data Acquisition System.
As shown in Figure 3.3, the catheter orifice is at point 1, where point 1 is located at an
elevation level h1 from the reference datum and the barrier, i.e., the stagnation point 2 is located at
an elevation level h2 from the reference datum. In order to show that, the stagnation point 2
experiences Ptotal, the Bernoulli’s energy conservation equations are written for points 1 and 2.
Noting that at point 1, the static pressure is P1 and the velocity is V1 and at point 2, the static
pressure is P2 and the velocity is V2. The following expression can be written using the Bernoulli’s
principle.
1
1
𝑃𝑃1 + ρ𝑉𝑉12 + ρ𝑔𝑔ℎ1 = 𝑃𝑃2 + ρ𝑉𝑉22 + ρ𝑔𝑔ℎ2
2
2
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(1)

1

1

In equation (1), 2 ρ𝑉𝑉12 and 2 ρ𝑉𝑉22 are the dynamic pressures, ρgh1 and ρgh2 are gravitational

heads at points 1 and 2, respectively. As the blood reaches the barrier, its velocity V2 at point 2
becomes zero, resulting in the equations (2) and (3).
1
𝑃𝑃1 + ρ𝑉𝑉12 + ρ𝑔𝑔ℎ1 = 𝑃𝑃2 + ρ𝑔𝑔ℎ2
2
1
𝑃𝑃1 + ρ𝑉𝑉12 + ρ𝑔𝑔(ℎ1 − ℎ2 ) = 𝑃𝑃2
2

(2)

(3)

Equation (3) proves that the barrier induces a pressure field equivalent to Ptotal into the
waveguide. It was also observed that the pressure field microphone partly cancelled out the Pstatic
data from the acquired Ptotal data through a static pressure equalization vent that was originally
designed to equalize the effect of ambient pressure [64] [65]. Therefore, it was concluded that the
acquired Ptotal predominantly consisted of pressure data corresponding to Pdynamic and trace amounts
of Pstatic. This provided motivation to derive the Pstatic from the acquired Ptotal. In standard invasive
pressure measurement systems, Pstatic is the measured pressure and Ptotal is not measured. However,
in this study, both Pdynamic and Pstatic were measured by uniquely characterizing the acquired Ptotal
as described in the next chapter.
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CHAPTER 4: SIGNAL PROCESSING FRAMEWORK

4.1 Background of Processing Blood Flow Dynamics
The signal processing framework shown in Figure 4.1, follows a basic approach in the
extraction and analysis of Pstatic and Pdynamic from the measured Ptotal. Analyzing the acoustic field
using the Pdynamic processing framework resulted in the acoustic heart and respiratory pulses.
Reconstructing the pressure field using the Pstatic processing framework resulted in the extraction
of continuous blood pressure, i.e., systolic and diastolic pressures. Pstatic will be referred to as the
pressure field and Pdynamic as the acoustic field of the blood flow in the rest of this dissertation. As
shown in Figure 4.1, the acoustic field was processed using noise reduction and source separation
algorithms and the pressure field was processed using a novel compression and a sensor
attenuation factor regression model to result in the corresponding vital bio-signals.

Figure 4.1: Signal Processing Framework to Extract Vital Bio-signals from the Blood Flow
Dynamics.
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4.2 Acoustic Heart and Respiratory Pulse Computation Framework
Analysis and processing of Pdynamic is viewed as a problem that requires a combination of
active noise cancellation and source separation for SNR improvement and bio-signal extraction.
Pdynamic is the result of acoustical sound pressure created by the oscillation of the blood column at
the boundary of the barrier. Effectively, it is the sound of the blood flow or the acoustic field of
the blood flow. Since the measurement was made in a noisy clinical setting, the blood flow sound
was interfered by other acoustical sources present in the setting. Thus, in order to extract the biosignals with fidelity from this measurement, the acquired Pdynamic needed to be enhanced using a
noise cancellation technique.

Further, a comparative performance evaluation of spectral

subtraction and various Least Mean Squares (LMS) based adaptive noise cancellation techniques
was accomplished based on Noise Factor (NF) and Signal to Noise Ratio (SNR). In order to extract
multiple bio-signals from the noise enhanced signal, a source separation technique based on
Multiresolution Analysis (MRA) was also developed. The block diagram of the developed
framework for processing the blood flow acoustics is shown in Figure 4.2. In Figure 4.2,
measurements from the G.R.A.S 46 AD and 46 AE microphones are processed using noise
cancellation and source separation blocks to obtain the vital bio-signals.

Figure 4.2: Overview of Blood Flow Sound Processing.
4.2.1 Noise Cancellation
In the noise cancellation block, the microphone measurements are subject to initialization
where the data is decimated and segmented into frames. Then, the segmented data from both
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channels is processed using noise reductions algorithms that include spectral subtraction and LMS
based adaptive noise cancellation algorithms as described in the following subsections.
4.2.1.1 Spectral Subtraction
Spectral subtraction is a widely employed technique in applications that require
cancellation of interference from acoustic noise. Many studies used a single channel spectral
subtraction technique that assumed stationarity of the noise in order to improve the SNR of the
sound pressure measurement [66, 67, 68]. However, it has been shown by studies [69, 70] that a
multichannel spectral subtraction is not only computationally simple but also very efficient in
improving the SNR of sound pressure measurements, particularly when a part of the reference
acoustic noise is assumed to be superimposed into the sound pressure measurement by means of
an unknown system as shown in Figure 4.3. The fluid filled catheter and the waveguide from the
data acquisition system, as shown in Figure 3.3, were identified as the major components of the
system with unknown impulse responses through which the noise, n(n), that is correlated to the
reference acoustic noise, n0(n), gets superimposed onto the desired signal, x(n). In this study, a
spectral magnitude subtraction technique was implemented to remove the noise superimposed onto
the data channel. Figure 4.3 shows the block diagram of the implemented spectral subtraction
algorithm.

Figure 4.3: Block Diagram Representation of the Implemented Spectral Subtraction
Algorithm.
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In Figure 4.3, the implemented spectral subtraction algorithm includes a data channel that
measures the acoustic field of the blood flow dynamics, d(n), where n is the sample index, and a
noise channel that measures reference acoustic noise from the clinical setting, n0(n). The noisy
measurement, d(n), acquired in the data channel is a result of superimposition of the desired signal,
x(n) and a manifestation of the reference acoustic noise, n(n). Equation (4) provides time domain
model for the noisy measurement.
d(n) = x(n) + n(n)

(4)

Here, d(n) and n0(n) were passed through an initialization block that decimated the signals
from 10 kHz to 1 kHz and then segmented to 2 second long frames with 80% overlap. Each data
frame, di(n), where i is the frame index, and noise frame, n0i(n), was windowed using a rectangular
window and transformed into the frequency domain using the Discrete Fourier Transform (DFT).
Then, each incoming frequency transformed data frame, 𝐷𝐷𝑖𝑖 (𝑓𝑓), and noise frame, 𝑁𝑁0𝑖𝑖 (𝑓𝑓), were

subjected to magnitude spectral subtraction to provide an estimate of the desired signal |𝑋𝑋�𝑖𝑖 (𝑓𝑓)| as

shown in equation (5).

�𝑋𝑋�𝑖𝑖 (𝑓𝑓)� = |𝐷𝐷𝑖𝑖 (𝑓𝑓)| − �𝑁𝑁0𝑖𝑖 (𝑓𝑓)�

(5)

Equation (5) resulted in processing distortions by producing negative values in the
estimated magnitude spectrum owing to the variations of the noise channel spectrum. Hence, the
estimated magnitude spectrum, |𝑋𝑋�𝑖𝑖 (𝑓𝑓)|, is processed by the spectral flooring function to prevent
negative values in the estimated magnitude. Equation (6) presents the function that was used to

perform spectral flooring [66, 71].
0.01|𝐷𝐷𝑖𝑖 (𝑓𝑓)|
|𝑋𝑋�𝑖𝑖 (𝑓𝑓)|= �
|𝑋𝑋�𝑖𝑖 (𝑓𝑓)|
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if |𝑋𝑋�𝑖𝑖 (𝑓𝑓)| < 0
otherwise

(6)

The spectral floored magnitude spectrum estimate,|𝑋𝑋�𝑖𝑖 (𝑓𝑓)|, is combined with the phase of

the noisy signal spectrum, θ(𝐷𝐷𝑖𝑖 (𝑓𝑓)), and then transformed into the time domain via the Inverse

DFT (IDFT). Finally, concatenating the outputs from the IDFT yielded an estimate of the desired
signal 𝑥𝑥�(𝑛𝑛).

4.2.1.2 Adaptive Noise Cancellation
Adaptive noise cancellation is another widely used multichannel noise cancellation
technique to remove acoustic noise interference. In particular, the current research evaluates the
performance of the various adaptive noise cancellation algorithms in such a configuration where a
part of the reference acoustic noise is assumed to be superimposed onto the data channel as shown
in Figure 4.4. In order to determine the best noise cancellation technique, the performance of the
LMS, sign LMS, normalized LMS and fast block LMS algorithms were compared with spectral
subtraction.

Figure 4.4: Block Diagram Representation of the Implemented Adaptive Noise Cancellation
Algorithm.
The configuration considered in Figure 4.4 is similar to the case that was considered for
the spectral subtraction based noise cancellation; where the noisy measurement, d(n), acquired in
the data channel is a result of superimposition of the desired signal, x(n), and a manifestation of
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the reference acoustic noise, n(n), as shown in equation (4). It is the assumption that the desired
signal, x(n), is statistically independent of n(n) and n0(n); n(n) and n0(n) are correlated in some
sense. In this algorithm, both d(n) and n0(n) were passed through an initialization block that
decimated the signals from 10 kHz to 1 kHz and then normalized. The normalized noise, n0(n), is
filtered to produce 𝑛𝑛�(𝑛𝑛), an estimate of n(n) using minimum mean square estimation. Equations
(7), (8), and (9) represent filtering, error computation and weight update operations of the LMS
based adaptive noise cancellation algorithm, respectively.
𝑛𝑛�(𝑛𝑛) = 𝑤𝑤 𝑇𝑇 (𝑛𝑛) ∗ 𝑛𝑛0 (𝑛𝑛)
𝑒𝑒(𝑛𝑛) = 𝑑𝑑(𝑛𝑛) − 𝑛𝑛�(𝑛𝑛)
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) + µ 𝑥𝑥(𝑛𝑛)𝑒𝑒(𝑛𝑛)

(7)
(8)
(9)

In equation (7), 𝑤𝑤 𝑇𝑇 (𝑛𝑛) represents the computed coefficients of the adaptive filter based on

the order (M), µ provides the step size for the weight update operation, e is the computed error
which is considered to be the noise free estimate 𝑥𝑥�(𝑛𝑛) and n is the sample index. In the current

study, M was set to 300 and µ was set to 0.01 for LMS. Sign LMS and normalized LMS were
implemented using (10) and (11), respectively.
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) + µ 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠(𝑥𝑥(𝑛𝑛))𝑒𝑒(𝑛𝑛)
µ2
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) +
𝑥𝑥(𝑛𝑛)𝑒𝑒(𝑛𝑛)
𝛥𝛥 + 𝜎𝜎𝑛𝑛20 (𝑛𝑛)

(10)
(11)

In equation (10), sign represents a standard signum function. In equation (11), Δ is a
constant and σ is the standard deviation of n0(n) which depends on the order of the filter. For sign
LMS, M was set to 300 and µ was set to 0.01. For normalized LMS, M was set to 300, µ was set
to 0.3 and Δ to 0.1. The block LMS was implemented using a Fast Fourier Transform (FFT) based
algorithm as described in [72]. The µ was set to 0.5, the block size and M were set to 300, the
forgetting factor (γ) and initial average power estimate (P) were set to 0.1.
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4.2.1.3 Performance Comparison of Noise Cancellation Algorithms
In order to assess the performance of the implemented noise cancellation techniques,
evaluation metrics based on the NF and the SNR estimated averages were computed after
application of each noise cancellation technique. The average of NF is estimated between the
corresponding variances (σ2) of d(n) and 𝑥𝑥�(𝑛𝑛). Prior to computing the averages of NF and SNR,

an estimate of the noise 𝑛𝑛�(𝑛𝑛) is computed by subtracting 𝑥𝑥�(𝑛𝑛) resulting from the noisy
measurement, d(n). Then, the SNR is estimated between the corresponding variances (σ2) of noise

free estimate 𝑥𝑥�(𝑛𝑛) and 𝑛𝑛�(𝑛𝑛). It should be noted that, d(n), 𝑥𝑥�(𝑛𝑛) and 𝑛𝑛�(𝑛𝑛) were segmented into 2

second long frames with 80% overlap before estimating the averages of NF and SNR. In the
equations (12) and (13) i, v, and l represent frame index, number of frames and frame length
respectively. NF is the ratio of powers of the noisy signal, di(n), to the noise free signal, 𝑥𝑥�𝑖𝑖 (𝑛𝑛). On

the other hand, SNR is the ratio of powers of noise free signal, 𝑥𝑥�𝑖𝑖 (𝑛𝑛), to the estimated noise, 𝑛𝑛�𝑖𝑖 (𝑛𝑛).
NF =

2
𝜎𝜎�𝑑𝑑
(𝑛𝑛)�
𝑣𝑣
∑𝑖𝑖=1 10 log � 2 𝑖𝑖 �
𝑣𝑣
𝜎𝜎� 𝑥𝑥� (𝑛𝑛)�

1

1

SNR = 𝑣𝑣 ∑𝑣𝑣𝑖𝑖=1 10 log �

𝑖𝑖
𝜎𝜎�2𝑥𝑥� (𝑛𝑛)�
𝑖𝑖
𝜎𝜎�2𝑛𝑛
� 𝑖𝑖 (𝑛𝑛)�

(12)

�

(13)

Table 4.1 shows the estimated averages of NFs and SNRs corresponding to the spectral
subtraction, LMS, sign LMS, normalized LMS and fast block LMS algorithms respectively.
Lower value of the estimated NF and higher value of estimated SNR are indicative of greater
proportion of noise being removed. Hence in comparison, the algorithm that provides a lowest
value of NF and a highest value of SNR is considered to be performing better.
Table 4.1: Estimated Average NFs and SNRs.
Noise Cancellation
NF(dB)
Spectral Subtraction
20.54
LMS
25.43
Sign LMS
22.46
Normalized LMS
25.12
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SNR(dB)
-8.16
-9.75
-8.48
-9.76

Fast Block LMS

Table 4.1 (Contd.).
25.38

-9.20

After application of spectral subtraction, Ptotal shows an average estimated SNR of -8.16
dB. Figure 4.5a shows the noisy measurement that was recorded at a critical care setting using the
G.R.A.S 46 AD microphone. The noisy data is corrupted mainly due to acoustical artifacts
generated from background speech, critical and emergency care instruments such as mechanical
ventilator and the patient monitors. Specifically, it was observed that a very low frequency periodic
noise due to a combination of hissing and thumping sounds was generated by the mechanical
ventilator. This periodic artifact left a significant impact on the SNR of the measurement which
can be seen around 10 and 50 seconds in Figure 4.5a. Spectral subtraction also provided
considerable attenuation to the artifacts (see Figure 4.5b). On the other hand, the average estimated
SNR of Ptotal after adaptive noise cancellation based on LMS and sign LMS were found to be -9.75
and -8.48 dBs, respectively. Figures 4.5c and 4.5d show the resultant outputs of LMS and sign
LMS. With respect to normalized LMS and fast block LMS, the post noise cancellation average
estimated SNR were found to be -9.76 and -9.20 dBs, respectively. Specifically, normalized LMS
and fast block LMS have not provided considerable artifact attenuation in comparison to other
noise cancellation techniques. See Figures 4.5e and 4.5f.
Though sign LMS quantitatively provides almost similar performance to that of spectral
subtraction, spectral subtraction outperformed the sign LMS in attenuating the artifacts and
providing better estimates of NF and SNR especially in the periods of d(n) where the artifact is not
present. Thus, it was concluded that the spectral subtraction provides efficient performance in
estimating x(n) from d(n) compared to the LMS, sign LMS, normalized LMS and fast block LMS
algorithms.
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Figure 4.5a: Noisy Measurement.

Figure 4.5b: SNR Enhanced Signal Using
Spectral Subtraction.

Figure 4.5c: SNR Enhanced Signal Using
LMS Based ANC.

Figure 4.5d: SNR Enhanced Signal Using
Sign LMS Based ANC.

Figure 4.5e: SNR Enhanced Signal Using
Normalized LMS Based ANC.

Figure 4.5f: SNR Enhanced Signal Using
Block LMS Based ANC.
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4.2.2 Source Separation
The noise reduced signal is then processed using the source separation block. This single
channel observation is decomposed into various levels using discrete wavelet transform where
only vital bio-signals of interest are then hard thresholded and reconstructed back. The details of
these blocks of source separation are described in the following subsection.
4.2.2.1 Wavelet Based Source Separation
Preliminary results of Hashiodani et al. [73] indicated that analyzing the sounds acquired
from an arterial body site can potentially include information with respect to bio-signals like heart
sounds, sounds of blood stream, and respiratory sounds. As a result, it was assumed that the
analysis of enhanced Pdynamic, i.e., sound of blood flow, would provide information with respect to
bio-signals like heart and respiratory sounds. In this context, studies [74, 75] that used timefrequency transformation techniques to localize heart sounds from respiratory sounds have shown
promising results especially for single channel source separation. Therefore, in this study a
wavelet based MRA has been implemented in order to unmask the underlying bio-signals. In
MRA, the given signal 𝑥𝑥�(𝑛𝑛), i.e., SNR enhanced Pdynamic is decomposed into various levels of
approximation (A) and detail (D) coefficients according to equation (14).
𝐴𝐴𝑚𝑚 (𝑛𝑛) = < 𝑥𝑥�(𝑛𝑛), 𝜑𝜑𝑚𝑚𝑚𝑚 (𝑛𝑛) >
𝐷𝐷𝑚𝑚 (𝑛𝑛) = < 𝑥𝑥�(𝑛𝑛), 𝜓𝜓𝑚𝑚𝑚𝑚 (𝑛𝑛) >

(14)

where <.> operator represents inner product, m represents the decomposition level, k represents
the translation, 𝜓𝜓 represents the mother wavelet with R vanishing moments and 𝜑𝜑 corresponds to

its scaling function. In order to obtain the approximations and details of the subsequent levels, the
wavelet (𝜓𝜓) and scaling (𝜑𝜑) functions are represented as recursive functions given in equation (15)
[76].
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∞
∑ h(p) 𝜑𝜑(2n – p)
p = −∞
∞
𝜑𝜑(n) = ∑ g(p) 𝜑𝜑(2n – p)
p = −∞

𝜓𝜓(n) =

(15)

In equation (15), h(p) and g(p) are impulse responses of low pass and high pass quadrature
mirror filters, respectively. The approximation and detail coefficients at each level are a result of
the convolution between the signal 𝑥𝑥�(𝑛𝑛) with the impulse responses of h(p) and g(p). The

approximation coefficients obtained at each level are down sampled by a factor of two and
decomposed further into finer approximations and details. This process was continued until all
the levels of the MRA were reached. After all the approximation and detail coefficients were
obtained from the MRA, the coefficients corresponding to all the scales were set to zero except for
the coefficients of the interest in a particular level. This hard thresholding process has been
adopted in this current study to unmask bio-signals in the wavelet domain.

Finally, after

application of the thresholding, the new coefficients were reconstructed back into the time domain.
Both the acoustic heart and respiratory pulses exhibit a different behavior in the wavelet domain
in the sense that the acoustic heart pulses are highly dynamic and non-stationary; on the other hand,
acoustic respiratory pulse is relatively slow varying [75]. Therefore, the chosen mother wavelet
(𝜓𝜓) should provide a reasonably good low and high frequency resolution to the underlying biosignals of 𝑥𝑥�(𝑛𝑛) through compact support. Additionally, the lower cutoff frequency of the pressure

field microphone was set to 3.15 Hz. Therefore, any underlying bio-signals of interest that
contained frequency components below 3.15 Hz would have been attenuated and appeared as
discontinuities in the measured pressure data. As a result, the chosen 𝜓𝜓 need to be able to detect

the presence of hidden discontinuities. Finally, the 𝜓𝜓 should be orthogonal to avoid phase
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distortions from the transformation. All the requirements of the current study were satisfied by
the Coiflet wavelet with four vanishing moments.
4.2.2.2 Results of Source Separation
The estimate 𝑥𝑥�(𝑛𝑛) from spectral subtraction was subjected to MRA using fourth order

Coiflet wavelet. The level of decomposition at which the detail coefficients were retained was

bio-signal dependent and thus for acoustic heart pulses the coefficients of interest were identified
at level four and for acoustic respiratory pulses the coefficients of interest were identified at level
ten. Following the ten level MRA decomposition, coefficients of interest in a particular level were
retained and a hard threshold was applied to coefficients corresponding to other scales. The
acoustic heart and respiratory pulses masked in 𝑥𝑥�(𝑛𝑛) were extracted by performing a hard

threshold on MRA coefficients, simultaneously retaining details coefficients of level four (D4),
level ten (D10) and reconstructing them individually back into the time domain. Figures 4.6a and
4.6b show the extracted acoustic heart and respiratory pulses obtained after reconstruction.

Figure 4.6a: Extracted Acoustic Heart Pulses.
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Figure 4.6b: Extracted Acoustic Respiratory Pulses.
The acoustic heart pulses were benchmarked by computing average heart rate in beats per
minute (bpm) and comparing it to the average of heart rate that was recorded prior and postacquisition of the noisy measurement. Since the acoustic respiratory pulse is a slowly varying
waveform, further analysis was done on a relatively large time period. A first order sample
difference was computed in order to identify the presence of any discontinuities that may have
been present due to the bandlimited frequency response of the pressure field microphone. The
corresponding results are shown in Figure 4.7.
From Figure 4.7, it can be observed that the slow moving respiratory signal was attenuated
and discontinuities were introduced due to this attenuation. The number of discontinuities present
were in direct correlation to the average respiratory rate in breaths per minute (rpm) acquired prior
and post the d(n) acquisition for the purpose of benchmarking. The discontinuities can also be
identified using MRA. The extracted acoustic respiratory pulse was decomposed into first level
approximation and detail coefficients using fourth order Coiflet wavelet to obtain similar results.
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Figure 4.7: Acoustic Respiratory Pulse and the Corresponding Discontinuities.
4.2.2.3 Validation
Table 4.2 presents the error analysis results of computed heart and respiratory rates
benchmarked with modalities obtained using conventional devices for all the venous and arterial
blood flow dynamics given in Table 3.1.
Table 4.2: Error Analysis Results of Heart Rate and Respiratory Rate Benchmarking.
Heart Rate (bpm)
Respiratory Rate (rpm)
Index
Recorded
Computed
Error Recorded
Computed
Error
Value
Value
(± %)
Value
Value
(± %)
1a
95
99
10
10.5
5a
110.5
102
3.78
10
10
5
6a
128
120
10
11
1b
218
210
10
11.5
5b
216.5
217.5
0.59
10
11.5
15
6b
222
225
10
11.5
2b
108.5
105
10
11
3a
116
112.5
1.87
10
11.5
13
4b
96.5
97.5
10
11.5
2a
179
180
10
10
3b
200
195
2.38
10
11
5
4a
204.5
194.6
10
10.5
The error percentage computed by benchmarking with conventionally measured modalities
validate the extracted acoustic heart and respiratory pulses. From Table 4.2, it was observed that
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the novel catheter multiscope measures the heart rate with an estimated error less than 4%, i.e.,
with higher precision when compared to the current heart rate monitors [77]. With respect to the
respiratory rate, the proposed catheter multiscope recorded the largest estimation error of 15% (1.5
rpm), which is within the acceptable tolerance and can be regarded as a comparable measurement
to an optimized respiratory rate monitor [78].
4.3 Continuous Blood Pressure Computation Framework
Continuous blood pressure was extracted from Ptotal following a novel signal processing
framework shown in Figure 4.8. Even though static pressure was equalized, it was observed that
measured Ptotal consisted of traces of Pstatic due to the insufficient discharge time constant of the
pressure field microphone.

Making use of this limitation, normalized blood pressure was

extracted, i.e., Pstatic was extracted by computing the local mean for every 25 ms from the measured
Ptotal. This local mean computation effectively compressed the number of data samples of Ptotal
from 10000 samples to 40 samples for each second. The segment length for mean computation
was deliberately chosen to be 25 ms since all the harmonics of blood pressure signal are present
between 0 to 20 Hz. Extraction of Pstatic from Ptotal resulted in normalized blood pressure. The
computed normalized blood pressure was further validated by establishing comparison between
the human and animal blood pressure data. This comparison was accomplished by estimating the
magnitude squared coherence between the normalized blood pressure data derived from recording
index 1a and the Physionet arterial blood pressure derived from a mutli-parameter waveform
database using Welch’s overlapped segment averaging.
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Figure 4.8: Overview of Continuous Blood Pressure Computation Framework.
4.3.1 Blood Pressure Estimation and Validation
From the extracted normalized blood pressure, it is not possible to directly estimate the
systolic and diastolic pressure. To estimate pressures, the pressure field microphone attenuation
factors k1, k2 corresponding to systolic and diastolic pressures were first estimated using the
regression model shown in equation (16), where sys is the systolic pressure, dia is the diastolic
pressure, M is the mean arterial pressure obtained using the conventional devices, P is the local
maxima and V is the local minima of the normalized blood pressure obtained after compression of
Ptotal. k1 and k2 are the sensor attenuation factors corresponding to the systolic and the diastolic
pressures.
sys = k1 . (P + M)
dia = k2 . (V + M)

(16)

The regression model first estimates the systolic and diastolic attenuation factors using the
blood pressure data obtained from conventional instruments, i.e., M, sys and dia. The systolic and
diastolic pressures were then estimated using the computed regression model.

The sensor

attenuation factors k1 and k2 were computed using the normalized blood pressure data for recording
indices 1a to 6b. The factors k1 and k2 were found to be 1.1078 ± 0.0658 and 0.8854 ± 0.0449,
respectively. Later, the mean values of the obtained k1 and k2 are used to compute average systolic
and diastolic pressures using equation (16) for all the recording indices from 1a to 6b as shown in
Table 4.3.
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Table 4.3: Error Analysis Results of Systolic and Diastolic Pressures Benchmarking.
Systolic Pressure (mmHg)
Diastolic Pressure (mmHg)
Recording
Recorded
Computed
Error
Recorded
Computed
Error
Index
Value
Value
(± %)
Value
Value
(± %)
1a
84.5
82.5
63
65.96
5a
45
41
3
31.5
32.6
1.5
6a
39
39.9
34
31.9
1b
189.5
196.6
152.5
157.2
5b
181
187.8
5
152.5
150.1
1.9
6b
141
152.9
133
122.2
2b
52.5
49.9
39
39.8
3a
44.5
42.1
5.6
30.5
33.6
4.2
4b
51
47.6
37.5
38.1
2a
124
135.7
110
108.5
3b
171.5
175.6
4.1
143
140.3
2.4
4a
186.5
190.5
158
152.3
From Table 4.3, it can be observed that the novel catheter multiscope is able to predict
systolic pressures with an estimated average error rate less than 6% and diastolic pressures with
an estimated average error rate less than 5% in comparison to the current gold standard. It should
be noted that, at this point results obtained for continuous blood pressure are considered to be
preliminary since the systolic and diastolic pressures have been approximated from a sensor
attenuation factor model. Additional benchmarking was accomplished with a human blood
pressure data to confirm the validity of described blood pressure estimation approach. Details are
provided in Appendix A.
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CHAPTER 5: APPLICATION CASE STUDIES
5.1 Sinus Rhythm Pattern Recognition 3.
5.1.1 Background
The centers for disease control and prevention estimates that more than 600,000 people die
of heart diseases every year in United States [79]. In addition to this overwhelming number of
heart disease cases, critical care units in the United States have reported a 90% false arrhythmia
alarm rate. Blood pressure, heart and respiratory rates are among other vital bio-signals that are
acquired and monitored in critical care units [80]. No other comparable studies in the literature
have described a diagnostic system that is capable of providing multiple vital bio-signals and
detecting an arrhythmia. Hence, our motivation is to develop a multiple bio-signal feature
extraction and pattern recognition framework for biomedical acoustic signals. In order to
demonstrate the feasibility of the developed framework, preliminary results are presented by
processing the acoustic heart pulses of the catheter multiscope
The blood flow sounds collected from various body sites in the current case study under
the conditions of normal and abnormal sinus rhythms are analyzed using an extended version of
the previously validated signal processing framework. See Figure 4.2. The extended framework,
initially extracts the acoustic heart and respiratory pulses from the measured blood flow sounds

3

A preliminary version of the content presented in Chapter 5, section 5 has been published in proceedings of 2017
International Conference of Software and Smart Convergence [125] and NIH-IEEE 2017 Special Topics conference
on Healthcare Innovations and Point of Care Technologies: Technology in Translation [124].
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using a noise cancellation and wavelet source separation technique based preprocessing. Then, the
extracted acoustic heart pulses are post processed to recognize the patterns of the sinus rhythm
based on a novel feature extraction technique and cluster analysis. The developed framework was
qualitatively and quantitatively validated by providing visual results of the clustering and by
computing the clustering accuracy, sensitivity and specificity. The cross validation results show
that the developed framework consistently recognizes the patterns of the sinus rhythms with an
accuracy rate of 94.37%.
5.1.2 Pattern Recognition Framework
Analysis and processing of the acquired dynamic pressure, i.e., blood flow sounds, was
viewed as a problem that requires a combination of preprocessing, feature extraction and
clustering. Since the measurement was made in a noisy clinical setting, measurement of this blood
flow sound was interfered by other acoustical sources present in the setting. Thus, in order to
extract the bio-signals with fidelity from this measurement, noise had to be reduced using a spectral
subtraction based noise cancellation technique. Next, the noise reduced signal was preprocessed
with the wavelet source separation in order to extract acoustic heart and respiratory pulses. Later
the extracted acoustic heart pulses were segmented; features were extracted and the pattern was
then recognized from the extracted features. The developed feature extraction and pattern
recognition technique was able to independently cluster normal and abnormal sinus rhythm
patterns of the acoustic heart pulses. Figure 5.1 shows the developed signal analysis and processing
framework for biomedical acoustic signals. The acoustic heart pulses obtained by processing the
signals of the catheter multiscope, as described in section 4.2 were processed further through
feature extraction and pattern recognition. The features multiscale energy was extracted and then
its pattern was recognized using K-Means clustering as explained in the following sections.
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Figure 5.1: Biomedical Acoustical Signal Analysis and Processing Framework.
5.1.2.1 Feature Extraction and Cluster Analysis
5.1.2.1.1 Multiscale Energy
A Continuous Time Wavelet Transform (CTWT) based feature called multiscale energy
was developed and computed for each segment of the acoustic heart pulse. The normalized CTWT
of a continuous signal h(t) is given by equation (17).
Wh;𝜓𝜓 (τ, s) =

∞
t−τ
∗
� h(t) ∗ 𝜓𝜓 � s � dt
√s −∞

1

(17)

Here W is the computed continuous wavelet transform, h(t) is a segment of the acoustic
heart pulse, s is the scale coefficient associated to stretching or compression of the signal in time,
τ is the translation parameter, 𝜓𝜓 is the chosen mother wavelet [81]. The Multiscale Energy (ME)

is computed using equation (18).

𝑀𝑀𝑀𝑀(𝑠𝑠) = �� Wh;𝜓𝜓 (τ, s)�
𝜏𝜏

2

(18)

The ME feature is computed at each scale of the CTWT of h(t) using Coiflet wavelet with
four vanishing moments as chosen mother wavelet.
5.1.2.1.2 K-Means Clustering
K-means clustering algorithm was applied to ME features of the acoustic heart pulse
segments for sinus rhythm pattern recognition. The following procedure adapted from [82] is
implemented to cluster the ME features:
1. Input the computed ME feature vector set, v, of the extracted acoustic heart pulses to KMeans algorithm.
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2. Randomly select the initial cluster centers from the feature set whose dimension is nb1 x
nb2 x np x fp. Here, nb1 represents the number of body sites, nb2 is the number measurements
taken at each body site, np is the number of segments and fp represents the number of
features per segment or feature index, i.e., features computed based on the scale vector of
the CTWT.
3. Assign the features that are closest to the cluster centroids according to the Euclidean
distance function shown in equation (19) to the cluster number (j) depending on the
maximum number of clusters, K, and nb1 x nb2 x np.
𝐾𝐾 𝑛𝑛𝑏𝑏1 × 𝑛𝑛𝑏𝑏2 × 𝑛𝑛𝑝𝑝

�
𝑗𝑗=1

�

𝑝𝑝=1

𝑗𝑗

�𝑣𝑣𝑝𝑝 − 𝑐𝑐𝑗𝑗 �

2

(19)

4. Recompute the centroids based on the formed new clusters.
5. Iteratively repeat the steps 2, 3 and 4 until the Euclidean distance function reaches
convergence.
5.1.3 Results and Discussion
After preprocessing the blood flow sounds, further analysis was done on the extracted
acoustic heart pulses corresponding to normal and abnormal sinus rhythms. The extracted acoustic
heart pulses were segmented into three second long segments and the ME features were computed
for each segment of the acoustic heart pulses. It has to be noted that, the number of body sites is

Figure 5.2: Feature Extraction and Pattern Recognition Dimensionality.
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2; the number of measurements at each body site, nb2, is 2; the number of segment instances, np, is
40 and the number of features per segment, fp, is 116. Figure 5.2 is provided to show the
dimensionality of the data when feature extraction and pattern recognition is performed.
Also, prior clustering, features corresponding to different body sites and sinus rhythm
patterns were randomly grouped to obtain a final feature set with dimensions resulting in (2 x 2 x
40) x 116, where 2 x 2 x 40 is the segment index corresponding to acoustic heart pulses of both
normal and abnormal sinus rhythms of carotid artery and jugular vein. Figures 5.3a and 5.3b show
the ME features computed for acoustic heart sounds of normal and abnormal sinus rhythm
segments of the carotid artery. In Figures 5.3a and 5.3b, each color represents the features (1x116)
per segment. Figures 5.3a and 5.3b show the ME features computed for acoustic heart sounds of
normal and abnormal sinus rhythm segments of the carotid artery. In Figures 5.3a and 5.3b, each
color represents the features (1x116) per segment.

Figure 5.3a: ME of Acoustic Heart Pulse Corresponding to Normal Sinus Rhythm.
The computed ME features are scaled and separated into 2 clusters using Euclidean
distance based K-means clustering algorithm. The cluster number (K) has been selected based on
the average silhouette coefficient (Cp) computation given in [83]. The Cp for the data used in the
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Figure 5.3b: ME of Acoustic Heart Pulse Corresponding to Abnormal Sinus
Rhythm.
current case study was determined to be 2 which can be associated to clusters corresponding to
normal and abnormal sinus rhythms. Figure 5.4 shows the qualitative results of K-means
clustering.

Figure 5.4: Qualitative Results of K–Means Clustering.
It can be observed from Figure 5.4 that K-means provides a satisfactory sinus rhythm
pattern recognition by separating the ME features into two different clusters. To further validate
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the developed ME features and the clustering framework, quantitative factors such as sensitivity,
specificity and accuracy have been computed from a cross validation based confusion matrix.
Cross validation was accomplished by mixing the final feature set and performing clustering on
the mixed feature set. It has to be noted that the clustering was accomplished by randomizing the
feature set mixture up to 10 times. Finally, average values of the quantitative factors of the
confusion matrix were computed. Table 5.1 presents the averaged results of the confusion matrix
of the cluster analysis.
Table 5.1: Confusion Matrix of the Cluster Analysis.
np = 160
Sinus Rhythm: Normal
Sinus Rhythm: Abnormal
Predicted: Normal Sinus
TN = 73
FN = 2
Rhythm
Predicted: Abnormal
FP = 7
TP = 78
Sinus Rhythm
The confusion matrix shown in Table 5.1 was computed for 160 segment instances. The
segment instances corresponding to the normal sinus rhythm was defined as True Negative (TN),
i.e., cluster number 0 and the abnormal sinus rhythm was defined as True Positive (TP), i.e., cluster
number 1. Sensitivity and specificity were computed from Table 2 to show that the developed
framework recognizes the patterns of the normal sinus rhythm with 91.25% precision and
abnormal sinus rhythm with 97.5% precision. In addition, it was also noted that the overall ability
of the developed framework in recognizing the patterns of the sinus rhythms was accurate to
94.37%.
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5.2 Fetal Phonocardiography 4
5.2.1 Background
The Centers for Disease Control and Prevention (CDC) estimates that more than one
million fetal deaths occur in the United States per year [84]. Complications such as preterm
delivery, hypoxia, intrauterine growth retardation and others, not only lead to fetal distress and
neonatal death but also can cause risks to maternal health. There is a lesser knowledge about the
incidence, etiology and prevention strategies for these complications; therefore it is critical to
monitor the status of both fetal and maternal health throughout pregnancy. Consequently,
Electronic Fetal Monitoring (EFM) was introduced in 1960s as a valuable tool for diagnosing Fetal
Heart Rate (FHR) during the antepartum and intrapartum periods of pregnancy [85]. Today, EFM
is used in 90% of the labor diagnosis procedures in the United States [86] and includes
Electrocardiography (ECG), Phonocardiography (PCG), Pulse Oximetry, Magnetocardiogram
(MCG) and Tocodynamometer. Organizations such as the International Federation of Gynecology
and Obstetrics (FIGO), the American College of Obstetricians and Gynecologists (ACOG), the
National Institute of Child Health and Human Development (NICHHD), the Royal College of
Obstetricians and Gynecologists (RCOG), and the National Institute of Clinical Excellence (NICE)
have standardized the use of EFM in conjunction with Maternal Uterine Contractions (MUC)
known as Cardiotocography (CTG) to optimize the outcomes for the mother and the new born
infant [87, 88].
Fetal Phonocardiography (FPCG) was discovered by the interventions of Marsac,
Kergardec and Kennedy during the 17th century [89, 90]. Although FPCG was discovered many

4

The contents in chapter 5, section 5.2 have been published in Journal of Biomedical Signal Processing and Control
[117] and proceedings of 36th Annual International Conference of the IEEE Engineering in Medicine and Biology
Society [126]
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years ago, interest in this research has only occurred over the last few years. Currently, the
application of FPCG is limited to FHR analysis and is seen as a noninvasive means for data
acquisition; it is only used as a secondary diagnosis tool in the antepartum, and has never been
utilized for complete clinical diagnosis. There are few reasons as to why FPCG is not clinically
accepted for a complete diagnosis: First, the FPCG is very noisy, owing to the fact that the
acquired signal is a mixture of fetal acoustic components, maternal acoustic components and many
other noises. Second, the characteristics of the aforementioned components are highly dependent
on the location of data acquisition, gestational age, fetal and maternal positions which result in
signal non-stationarity; finally, the non-linear transmission medium dynamically morphs all the
components to result in a narrow band signal. Today’s standard of care in fetal monitoring suspects
that the fetal heart rate is predictive of pregnancy complications [91]. As a consequence, EFM
relies predominantly on FHR and does not incorporate the characteristics of the FPCG waveform
in the assessment of fetal and maternal outcomes. The primary reason for the exclusion of this
information from clinical practice is that the technology to measure the Fetal Heart Sounds (FHS)
reliably is not yet available. Secondly, the existing signal processing techniques are unable to
deliver a FHS signal from the acquired FPCG signal without considerable distortion.
5.2.2 State-of-the-Art in Fetal Monitoring
The technologies available to accomplish fetal monitoring are FPCG, Fetal Ultrasound,
Fetal Electrocardiography (FECG) [20, 92], Fetal Magnetocardiography (FMCG) [93], Fetal Pulse
Oximetry/Photoplethysmography (FPPG) [94] and Tocodynamometer/Intrauterine Pressure
Catheter (IUPC) [95]. Among all these methods, ultrasound is regarded as the gold standard in
fetal monitoring and is widely used during pregnancy and labor. When ultrasound is used to obtain
biophysical profiles and images, typically during weeks 18 – 22, is known as echocardiography
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[96]; when ultrasound is used in conjunction with tocodynamometer/IUPC, typically employed
during labor and antepartum to acquire FHR and UC, is known as cardiotocography (CTG) [97].
Continuous fetal monitoring using ultrasound, particularly during labor, is highly challenging for
two main reasons: the transducer of the ultrasound’s data acquisition system needs frequent
realignment, and the constant presence of a highly trained operator during data acquisition is
required [98, 99]. Ultrasound technique is highly sensitive to movement, hence any maternal and
or fetal movement is known to affect the ultrasound’s beam reflection [100]. Also, long term and
ambulatory fetal monitoring using ultrasound is inappropriate due to complexity of the
instrumentation [100, 101]. Studies [101, 102, 103, 104] have shown that long-term and shortterm variability of FHR obtained from ultrasound data are not as precise when compared to other
techniques. Even if all the limitations of the ultrasound technique are rectified, ultrasound still
exposes the fetus to radiation. The safety of the fetus from this radiation exposure remains a
concern, due to the lack of evidence in the current literature [105, 106, 107, 108, 109, 110].
Besides these limitations, data obtained from FPCG contains more information on cardiac
abnormalities and pathologies than ultrasound in relation to fetus and mother [111]; hence, the
consideration of ultrasound as the gold standard is debatable. Most of the fetal cardiac
abnormalities are believed to have some manifestation on the morphology of the FECG and the
FMCG. However, they exhibit a poor Signal to Noise Ratio (SNR) due to unresolved maternal
and bio-signal interferences [102, 103] and they have a complex instrumentation [102, 112, 113].
Traditionally, FECG is known for producing the highest quality measurement of FHR, but it has
been shown within the literature that FHR from a FPCG signal is equally as reliable as FECG
[114]. The use of FPPG is also restrained, as the light emitted from the signal is known to increase
the fetal temperature, has a poor SNR due to the presence of ambient light and it has an optical
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shunt problem [115].

Henceforth, the current standards of fetal monitoring are unreliable

particularly during labor [116, 19]. On the other hand, though the FPCG has potential for fetal
monitoring during first and second trimesters as well as labor, its usage as a secondary diagnosis
tool is limited to antepartum as it suffers from low SNR due to maternal signal interference,
maternal motion, nonlinear transmission medium and limitations in the existing data acquisition
approaches and data acquisition systems.

If the existing data acquisition approaches, data

acquisition systems and signal processing techniques are improved, FPCG is capable of addressing
all the limitations that the other methods present. Based on this observation, motivation for
addressing the gaps of fetal monitoring through FPCG was found.
Acquisition, analysis, and processing of fetal heart sounds from maternal body is known
as FPCG. The signal acquired at the transducer is a superimposition of various time varying
acoustic and pressure components.

Essentially it consists of fetal acoustic and pressure

components: Fetal Heart Sounds (FHS), Fetal Movements (FM) that include Fetal Respiration
(FR), fetal hiccups, and body movements; maternal acoustic and pressure components: Maternal
Heart Sounds (MHS), Maternal Organ Sounds (MOS) that include Maternal Respiration (MR),
Maternal Uterine Contractions (MUC), Maternal Digestive Sounds (MDS), and Maternal Motion
(MM); additional signal components that include Power Line Interference (PLI), Reverberation
Noise (RN), Sensor and Background Noise (SBN).

These components provide invaluable

diagnostic information about the fetal and the maternal health; however, its analysis and processing
is rather challenging. In particular, the FHS signal has low SNR as it gets attenuated due to
transmission path losses, and also gets superimposed with other fetal, maternal and additional
components. Among all the components of FPCG, MHS overlap with FHS in both time and
frequency domains. Further, fetal position, maternal obesity, placental position and location of
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data acquisition play an important role in determining the SNR of the FHS signal and henceforth
the SNR of the FPCG. For these reasons, denoising and recovering FHS from FPCG requires
application of advanced signal processing algorithms.
In the literature, various signal processing techniques have been described to denoise the
FPCG ranging from simple digital filters to advanced source separation techniques [117]. Though
filtering and other heuristic methods are computationally efficient, these methods are not able to
completely reduce the MHS interference in FPCG. Consequently, to solve the problem of MHS
interference, adaptive filtering and blind source separation techniques have been implemented.
However, these techniques require data that is captured from multiple channels in order to
successfully denoise the MHS from FPCG and thus when it comes to single channel FPCG, these
techniques do not perform well. Though specific blind source separation techniques have also
been used to decompose FHS from a single channel FPCG, they fail to successfully retain time
domain characteristics of the FHS, in particular FHR. In summary, the proposed techniques suffer
to efficiently eliminate both the in-band and out-of-band noise present within a single channel
FPCG.
In order to address these challenges, a single channel FPCG processing framework has
been developed. This framework is capable of denoising the FPCG by accurately reconstructing
FHS while efficiently removing the MHS and out-of-band interferences. The proposed framework
first enhances the SNR of the noisy FPCG by removing the out-of-band noise using a single
channel enhanced spectral subtraction technique. The performance of the implemented denoising
algorithm is quantitatively assessed by computing Noise Factor (NF). Then, the SNR enhanced
FPCG is decomposed into FHS and MHS in time-scale domain using a wavelet based source
separation as shown for the catheter stethoscope in Figure 4.2. Finally, the recovered FHS and
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MHS are quantitatively validated by computing FHR, Maternal Heart Rate (MHR) and comparing
it to the standard values.
5.2.3 Fetal Phonocardiogram Processing Framework
Analysis and processing of a single channel FPCG signal was seen as a problem that
requires a combination of noise cancellation and source separation for noise reduction and biosignal interference resolution. The noise reduction technique was predominantly used to remove
the out-of-band noise such as fetal movements, maternal organ sounds and additional components
and in order to enhance the SNR of the noisy FPCG signal. A wavelet based source separation was
implemented to decouple the MHS from FPCG, i.e., the in-band noise in order faithfully recover
FHS. Figure 5.5 illustrates the framework that was used to process the single channel FPCG data.
The simulated fetal phonocardiogram signals are processed using similar noise cancellation and
source separation algorithms described earlier in section 4.2 and as shown in the block diagram in
Figure 5.5. The framework was validated using the simulated FPCG dataset extracted from the
PhysioNet database [118] [25]. Single channel FPCG signals corresponding to various SNR
conditions were subjected to the developed framework to assess its reliability.

Figure 5.5: Fetal Phonocardiogram Processing Framework.
5.2.3.1 Noise Cancellation
In this case study, an enhanced spectral magnitude subtraction technique was implemented
to remove the out-of-band noise superimposed onto the FPCG. Fetal movements, maternal organ
sounds and additional components are the major contributors of the out-of-band noise. In the
simulated FPCG dataset, the impulse responses of the out-of-band noise were identified to be either
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Gaussian or impulse noise. In particular, MDS, MR, FM and SBN were the sources of the
Gaussian noise; MM and RN were the sources of the impulse noise. The out-of-band noise is
estimated and updated from the periods when the FHS and MHS are absent.
The implemented spectral subtraction algorithm includes a data channel that consists of
noisy FPCG data, d(n), and a noise channel that estimates an ensemble average of the out-of-band
from the data channel, n(n). The d(n) and the n(n) were passed through an initialization block that
segmented to frames of length one second with 60% overlap between adjacent frames. Each data
frame, di(n), and noise frame, ni(n), where i is the frame index and n is the sample index, was
windowed using a rectangular window and transformed into frequency domain using Discrete
Fourier Transform (DFT). Then each incoming frequency transformed data frame, Di(f), and noise
frame, Ni(f), was subjected to magnitude spectral subtraction to provide an estimate of SNR
enhanced FPCG signal, �𝑋𝑋�𝑖𝑖 (𝑓𝑓)�, as shown in equation (5). Then the estimated signal is post
processed using equation (6) to remove nulls in the spectral domains before performing inverse
DFT.
5.2.3.2 Source Separation
In this case study, a wavelet based Multiresolution Analysis (MRA) has been implemented
in order to extract the FHS and MHS from the FPCG. In MRA, the given signal, 𝑥𝑥�(𝑛𝑛), i.e., SNR
enhanced FPCG is decomposed into various levels of approximation and detail coefficients. The

approximation and detail coefficients obtained after the MRA were hard thresholded based on the
bio-signal of interest and reconstructed back into time domain. The chosen mother wavelet should
provide a reasonably good frequency resolution to FHS and MHS, through compact support. The
mother wavelet needs to be able to detect the presence of hidden discontinuities. In addition, the
wavelet should also be orthogonal to avoid phase distortions from the transformation. All the
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requirements of the current case study were satisfied by the Coiflet wavelet with five vanishing
moments. In addition, qualitative correlation between Coiflet-5 wavelet and the heart sounds, fetal
and maternal, is very high.
5.2.4 Results and Discussion
In order to assess the performance of the developed noise cancellation algorithm, simulated
FPCG data corresponding to various SNRs were quantitatively evaluated using NF after noise
cancellation. Unavailability of the actual out-of-band noise n(n), FHS and MHS data was the main
reason behind choosing NF as a performance evaluation metric. In this case study, average NF was
estimated as ratio of variances of d(n) and 𝑥𝑥�(𝑛𝑛). It has to be noted that d(n) and 𝑥𝑥�(𝑛𝑛) were

segmented into frames of length one second and with 60% overlap between adjacent frames, where
i and v represent frame index, and number of frames before estimating the average NF as given in
equation (12). Table 5.2 shows the noise removal consistency of the developed noise cancellation
algorithm for various SNRs of the simulated FPCG data. Lower value of the NF indicates great
proportion of noise being removed.
Table 5.2: Estimated Average Noise Factors for FPCG.
Standard Deviation of FPCG
Noise Factor
Noise (dB)
(dB)
73.12
-4.20
74.76
-3.28
75.86
-2.41
76.42
-2.01
81.81
-0.97
From Table 5.2, it can be seen that the developed noise cancellation algorithm consistently
cancels the noise out from the FPCG even under conditions of increasing noise power. Post noise
cancellation, the estimate 𝑥𝑥�(𝑛𝑛) was subjected to a six level MRA using fifth order Coiflet wavelet.

The FHS and MHS were extracted as independent sources by performing a hard threshold on MRA
coefficients, simultaneously retaining details and approximation coefficients of level six (D6 and
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A6) and reconstructing them individually back into time domain. Figures 5.6.A1, 5.6.A2, 5.6.B1,
5.6.B2, 5.6.C1 and 5.6.C2 show the noisy signal with noise powers 73.12, 76.42, 81.81 dBs and
the corresponding FHS and MHS signals obtained after MRA decomposition for six seconds of
SNR enhanced FPCG, respectively.

Figure 5.6: Noisy FPCG, Separated FHS and Separated MHS Corresponding to Various FPCG
Noise Powers.
65

From Figures 5.6.A1 – 5.6.C2, it can be observed that, qualitatively the developed
framework effectively attenuated the out-of-band noises and efficiently resolved the FHS and
MHS interference from a single channel FPCG.

However, in order to provide additional

validation, mean Fetal and Maternal Heart Rates (FHR, MHR) along with their standard deviations
(SD) were computed in beats per minute (bpm) for the analyzed FPCG dataset. Table 5.3 presents
the results of the estimated FHR and MHR.
Table 5.3: Estimated FHR and MHR.
Standard Deviation of FPCG Noise (dB)
FHR±SD (bpm)
73.12
143±16
74.76
149±25
75.86
154±32
76.42
150±25
81.81
167±36

MHR±SD (bpm)
74±4
72±8
71±10
76±20
83±16

From Table 5.3, it can be seen that the estimated FHR and MHR fall within normal
range, i.e., 110-210 bpm for FHS and 70-90 bpm for MHS [117].
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CHAPTER 6: CONCLUSIONS AND FUTURE RESEARCH

6.1 Conclusions
Existing critical and emergency care blood flow based data acquisition systems are
currently limited to only measuring continuous blood pressure. Inability to detect sensitive
dynamic pressure variations and solve the problem of reducing external acoustic noise are the
primary limiting factors. In addition, the use of multiple monitoring systems such as 12-lead
electrocardiogram, capnogram, plethysmograph and Foley catheter present a plethora of other
challenges including complex and expensive infrastructure, lack of functional interoperability and
diagnostic precision in low resource settings. To address these challenges, a novel first of its kind,
catheter multiscope was introduced in this research. The results of the proof of concept and the
feasibility studies described in the dissertation show that the developed minimally invasive novel
catheter multiscope can be used to measure critical parameters with clinical accuracy. In particular,
the catheter multiscope is able to uniquely characterize a physiological phenomenon and
continuously measure critical parameters such as: heart rate, respiratory rate, systolic pressure and
diastolic pressure validated using small animal models. In comparison to the existing state-of-theart, the developed technology exhibits innovation in terms of complexity of the data acquisition
system, an efficient signal processing framework and an improved applicability for a low resource
setting. The sensitive dynamic pressure variations within the blood flow were acquired using a
data acquisition system that is a composed of a fluid coupled catheter, a fluid to air polymeric
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membrane and an acoustic waveguide housing a pressure field microphone. Since the acquired
dynamic pressure is severely affected due to other acoustic interferences present in critical and
emergency care setting, its signal to noise ratio was improved by developing an efficient spectral
subtraction based noise reduction algorithm. The performance assessment metrics such as noise
factor and signal to noise ratio quantitatively validated that the developed algorithm provides a
better performance compared to other state-of-the-art noise cancellation algorithms. Then, a
wavelet based source separation algorithm was developed to separate various acoustic sources
from a single channel observation. Using the novel source separation algorithm, acoustic heart and
respiratory pulses were extracted from the noise reduced signal. The framework to process the
acoustic signals of the novel catheter multiscope can be adapted to other single or multi-channel
acoustic signals with minor or no modifications.
It was observed that there were no particular standards to validate the results of critical care
data acquisition systems. Hence, in this dissertation, a procedure to validate and benchmark the
performance of critical care data acquisition systems has been developed. The extracted acoustic
heart and respiratory pulses were quantitatively validated by showing that the estimated average
errors for the computed heart and respiratory rates were less than 15%. In addition, continuous
blood pressure was derived from the measured total pressure by means of a novel signal processing
framework. The derived systolic and diastolic pressures were quantitatively and qualitatively
validated by benchmarking with the gold standard measurements and by establishing an additional
benchmark with Physionet arterial blood pressure data. The estimated average errors for the
computed systolic and diastolic pressures were less than 6%. Overall, the feasibility study shows
that the developed novel catheter multiscope can provide multiple critical parameters like heart
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rate, respiratory rate, systolic and diastolic pressures with clinical accuracy by measuring a
physiological process.
In addition to demonstrating the feasibility of the developed catheter multiscope in critical
and emergency care monitoring, the diagnostic potential of the developed technology has been
shown in additional applications including sinus rhythm pattern recognition and fetal monitoring
through phonocardiography. These application case studies are the byproducts of the catheter
multiscope, i.e., similar or the same data acquisition system and signal processing framework have
been utilized. The preliminary results show that it is feasible to measure multiple critical
parameters from a single physiological phenomenon using the catheter multiscope. The
methodology implemented in this research can be applied for research, development and
optimization of other catheter based data acquisition systems for monitoring vital bio-signals. In
conclusion, there is growing interest for disruptive technology like the catheter multiscope in the
field of medical devices particularly, in critical and emergency care. It is the ultimate goal of this
research to establish new frontiers in vital bio-signal monitoring for any critical and emergency
care under any given low resource settings.
6.2 Future Research
From the current feasibility study, it was observed that various challenges with respect to
the data acquisition system, data analysis and benchmarking have to be addressed in order to
extract all the bio-signals of interest with fidelity.
6.2.1 Data Acquisition
With respect to the data acquisition system, the Pstatic was not measured with precision since
the computed blood pressure waveform indicated the presence of distortions and resulted in an
attenuated signal. The acoustic respiratory pulse was attenuated and presented as discontinuities
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in the Ptotal. In order to address the challenges of the data acquisition system, Pstatic needs to be
measured with a suitable pressure sensor. The frequency response of the Ptotal measuring sensor
needs to be specified below 1 Hz to sense changes in the infrasonic sound pressures.
6.2.1.1 Future Design Optimizations
Though the pressure field microphone measures the dynamic pressures with high
sensitivity and precision, it requires the use of a waveguide to effectively acquire the dynamic
pressure. However, in order to comply with the regulations of FDA, the invasive/minimally
invasive critical care data acquisition systems are only to be designed for one-time use. For these
reasons, the use of waveguide and pressure field microphone make the data acquisition system
expensive. Hence, future generation devices will have to be cost effective and designed for onetime use. Figure 6.1 shows the next generation design layout of the catheter multiscope that is
capable of addressing the existing challenges.

Figure 6.1: Next Generation Design Layout for Catheter Multiscope.
As shown in Figure 6.1, the existing data acquisition system will be retrofitted using
retrofits 1 and 2. Retrofit 1 contains a MEMS based static pressure sensing element with a custom
sensor housing designed to estimate fluid pressure. In addition, retrofit 1 also contains a custom
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designed Y port, through which saline solution and other drugs can be infused. The Y port also
enables expansion of the monitoring to other critical parameters such as SPO2 and rapid blood
analysis. Retrofit 2 contains a polymeric barrier that is used to provide fluid to air coupling and a
MEMS microphone is fabricated on the barrier. This design of retrofit 2 eliminates the use of
waveguide and pressure field microphone. In addition to optimizing the data acquisition system
through retrofitting, computational fluid dynamics simulations will also be performed in future.
6.2.2 Data Collection and Signal Processing
With respect to data analysis, artifacts have not been processed and removed from the data
and hence before performing any analysis, artifacts need to be attenuated. It should also be noted
that this study did not consider evaluation metrics like mean squared error and computational
efficiency in assessing the performance of the noise cancellation algorithms which is proposed for
future research. Though MRA provided satisfactory bio-signal separation, the decomposition
coefficients in the scales of interest had to be manually identified in the current study and hence it
would be interesting to further process the MRA coefficients by an unsupervised clustering
algorithm like K-means, Gaussian Mixture Models, etc. Though the acoustic heart pulses were
extracted from the measured Ptotal without any distortion, it needs to be validated towards
identification of pathology pertaining to the heart sounds. With respect to benchmarking, in the
current study, additional modalities like respiratory rate and heart rate were noted prior and post
data acquisition and hence in order to provide an accurate benchmarking these modalities need to
be recorded electronically along with the Ptotal measurement. Also, the implemented blood pressure
computation framework needs additional information from the conventional devices. Regarding
continuous blood pressure, an accurate benchmark needs to be established in order to provide
conclusive results and this is currently under study. Overall, the current data acquisition and
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analysis were validated by acquiring vascular pressure measurements from small animal models
which needs to be extended to humans.
6.2.3 Application Case Studies
6.2.3.1 Sinus Rhythm Pattern Recognition
Analysis presented in this dissertation evaluated the developed cluster analysis framework
for the data collected from two different body sites. In order to validate the pattern recognition
framework, the current case study needs to be implemented for data collected from more than two
body sites and for various statically robust datasets collected from various animal studies. It should
be noted that the segmentation accomplished prior feature extraction is a key cluster accuracy
determining factor. In the current case study, the segmentation length has been chosen empirically
and for the future study the segmentation needs to be defined based on the clustering objective. In
order to improve currently obtained recognition accuracy of 94.37% for the developed framework,
a multimodal framework has to be developed that includes information from other vital bio-signals
of the catheter multiscope. Additionally, investigating multimodal features from blood pressure,
acoustic heart and respiratory pulses may also contribute to the accuracy improvement. It is also
worth noting that the current case study needs to be applied to various cases of pathological
arrhythmia. Overall, the current data acquisition and cluster analysis framework was validated by
acquiring vascular pressure measurements from a Yorkshire pig which needs to be extended to
humans. The end goal is to be able to reduce the false arrhythmia alarm rates of the critical care
units. In addition, the framework developed for the acoustic heart pulses of the catheter multiscope
can also be extended and validated for classification of normal and abnormal heart sounds.
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6.2.3.2 Fetal Monitoring Through Phonocardiography
Though the developed spectral subtraction algorithm was able to effectively remove the
out-of-band noise, the noise factor was seen to be reducing across higher noise power ranges.
Hence, in order to maintain consistent noise factor throughout all the power ranges of noise, the
noise estimation algorithm within spectral subtraction will need to be improved in the future. In
addition, a comparative analysis has to be performed with multiband spectral subtraction and other
recent denoising techniques. In this application, the source separation algorithm was able to
separate FHS and MHS from the simulated FPCG dataset. However, the proposed framework is
currently being extended to a clinically collected FPCG dataset. Also, as a part of this analysis,
the feasibility of separating additional vital bio-signals corresponding to the fetus and the mother
is being assessed. FHR and MHR were manually computed for this case study and in the future
this computation should be automated and validated against clinically collected cardiotocographs.
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APPENDIX A: ADDITIONAL VALIDATION FOR NORMALIZED BLOOD PRESSURE

For additional validation of normalized blood pressure data extracted from the novel
catheter multiscope, a frequency domain benchmarking was also performed with human blood
pressure. The rationale behind establishing comparison between the human and animal blood
pressure comes from the fact that specific animal models, particularly porcine and human
physiological data share similar characteristics [119].

Figure A.1(a) shows the normalized

continuous blood pressure computed from the catheter multiscope’s measurement and Figure
A.1(b) shows the arterial blood pressure data extracted from the PhysioNet waveform multiparameter database [120, 25] over a period of ten seconds.

Figure A.1: Normalized Blood Pressure of Catheter Multiscope and Arterial Blood Pressure
from the PhysioNet Database.
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This benchmarking was accomplished by estimating the magnitude squared coherence
between the blood pressure data derived from recording index 1a and the Physionet arterial blood
pressure using Welch’s overlapped segment averaging method with 5 second long frames and 75%
overlap. Figure A.2 presents the results of estimated magnitude squared coherence.

Figure A.2: Estimated Magnitude Squared Coherence.
It was observed that the magnitude squared coherence was dominant particularly around 2
Hz and 7 Hz. The Region of Interest (ROI) energy was estimated by computing the energy of the
normalized magnitude squared coherence over 0 – 10 Hz and 10 – 20 Hz frequency bands. The
ROI energy indicated that the derived blood pressure and Physionet blood pressure were
significantly correlated over a frequency band of 0 – 10 Hz. The additional blood pressure
validation results presented for the recording index 1a, shown in Figure A.2 is also applicable to
other recording indices described in Table 3.1.
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